Antisense Regulation and Tissue-specific Roles of Peg3 in Lactation and Maternal Care by Frey, Wesley D
Louisiana State University
LSU Digital Commons
LSU Doctoral Dissertations Graduate School
2015
Antisense Regulation and Tissue-specific Roles of
Peg3 in Lactation and Maternal Care
Wesley D. Frey
Louisiana State University and Agricultural and Mechanical College, wfrey1@lsu.edu
Follow this and additional works at: https://digitalcommons.lsu.edu/gradschool_dissertations
This Dissertation is brought to you for free and open access by the Graduate School at LSU Digital Commons. It has been accepted for inclusion in
LSU Doctoral Dissertations by an authorized graduate school editor of LSU Digital Commons. For more information, please contactgradetd@lsu.edu.
Recommended Citation
Frey, Wesley D., "Antisense Regulation and Tissue-specific Roles of Peg3 in Lactation and Maternal Care" (2015). LSU Doctoral
Dissertations. 4075.
https://digitalcommons.lsu.edu/gradschool_dissertations/4075
ANTISENSE REGULATION AND TISSUE-SPECIFIC ROLES OF PEG3 IN LACTATION 
AND MATERNAL CARE 
 
 
  
 
 
 
 
 
 
 
A Dissertation  
 
Submitted to the Graduate Faculty of the 
 Louisiana State University and  
Agricultural and Mechanical College 
 in partial fulfillment of the 
 requirements for the degree of  
Doctor of Philosophy  
 
in  
 
The Department of Biological Sciences 
 
 
 
 
 
 
 
 
 
 
by  
Wesley D. Frey 
B.S., Louisiana State University, 2010 
December 2015 
ii 
 
ACKNOWLEDGEMENTS 
First and foremost, I would like to thank Dr. Joomyeong Kim, my phenomenal mentor, for 
providing the enthusiasm, creativity and determination that was necessary to complete the 
ambitious projects that we were able to finish.  I would also like to thank my committee 
members, Dr. David Donze for his day to day pep talks and for instilling patience in me and Dr. 
Mark Batzer for his sense of humor and jovial perspective. I would also like to thank my original 
undergraduate mentor, Dr. James Moroney, who first introduced me to the majestic world of 
research and had the fortitude to bring me into his lab as an undergraduate.   
 
I would also like to thank my family.  My father, David Frey, for his infinite wisdom and his 
ability to judge character.  My mother, Patricia Mathews, for forcing me to study every day as a 
child and for help with every academic endeavor I ever took part in.  My sister, Danielle Frey, 
for making sure I was taken care of outside of the lab and for being the best sister possible.  My 
stepfather, Gary Mathews, for providing moral support at home and for giving insight into the 
realm of advanced academics.  And my grandparents, Daniel Frey, Lillian Frey, James McNary 
and Virginia McNary for their unconditional support.  Although they could not see me walk, I 
know it would make them proud. 
 
I would like to thank my earliest research mentor Tiffany Simms for providing me the 
foundation of my knowledge in experimental designs, providing the greatest advice on life and 
for introducing me to my eventual committee members and mentor. And to Dr. Hana Kim for 
providing a model for the initiative, drive and dedication I would need to complete graduate 
iii 
 
school.    She  still  is  the  hardest  working  person  I’ve  ever  met  and  taught  me  to  work  harder  than  
anything I ever thought was possible.    
 
I would like to thank Ms. Cathy Raziano, my high school biology AP teacher, who taught me to 
keep probing the academic landscape for more knowledge.  Although she was not able to teach 
experimental inputs, I cannot thank her enough for bringing me to my passion and being an 
incredible teacher.  
 
I would also like to thank the lab members from the Joomyeong Kim lab starting with the lab 
“secretary”,  Pinithi  Perera,  who  has  grown  into  an  amazing  scientist.    I  would  also  like  to  send  
tremendous thanks to Dr. Michelle Thiaville for her leadership in my Kim lab experience and 
teaching me how to work with cell culture.  Corey Bretz, for providing a great continual 
distraction from lab work and his maintenance of the original Peg3FlpKO line. Dr. Suman Lee for 
his humorous insights.  Austin Wong for helping with mammary dissections and Aaron Landry 
for providing a good template for this dissertation.  Terri Cain and Carter Pesson for helping in 
dissection of all the dams involved in this study, as well as An Ye for providing the Peg3 ChIP 
sample for testing Peg3-OxtR interaction.  I would also like to thank Terri Cain and Dr. Hana 
Kim for their help in cloning the regions for their help with ChIP experiments and the OxtR 
promoter assay.   To Dr. George Cooke, KimNgoc Tran, Himanshu Raje and Vallmer Jordan 
who have the most positive insights into the most dreadful situations that could face a graduate 
student.  Their outlook has helped tremendously in keeping a level head through graduate school.  
Kimberly LeBlanc, Drs. Richard Kleinschmidt and Asawari Korde, for being mentors to me at 
iv 
 
the times of my rotations through the Donze lab and beyond.  I thank Dr. Rui Lu for opening my 
eyes to the exciting world of RNAi and Dr. Ryoichi Teruyama for his insights into vasopressin 
and oxytocin. 
 
I would like to thank Ms. Christine Mayeux and Ms. Priscilla Milligan for all their administrative 
help and moral support through the years.  Jannelle Allen, for all her insights into mouse 
husbandry and teaching me the intricacies of parenthood in the mouse.  Past members of the 
Moroney lab, including Dr. Bratati Mukherjee, Robert DiMario, Katelyn Fusilier, Michael 
Sonnier, Kristin Bice, Trang Pham who were great friends as well as instrumental in getting my 
GPA up in my undergrad which was necessary for getting into the graduate school. 
 
Finally,  I  would  like  to  thank  the  members  of  the  Louisiana  Pipeliner’s  Association,  Mark  
Roberts, Nicky Smith, Tommy McNulty for their financial and temporal investment in my 
graduate studies and for keeping me grounded throughout my graduate years. 
 
I could not ask for better mentors in my life than these people.  I would also like to thank 
everyone who has contributed along the way that I may have forgotten in this acknowledgements 
section, because without every one of them I would not be who I am today.  I am 
overwhelmingly  grateful  for  their  insights  and  their  abilities  to  help  me.    Without  everyone’s  
support, I would probably just end up doing research in my garage, but with them I am able to 
accomplish all the goals set before me in research. 
v 
 
TABLE OF CONTENTS 
ACKNOWLEDGEMENTS.............................................................................................................ii  
LIST OF TABLES..........................................................................................................................vi 
LIST OF FIGURES.......................................................................................................................vii 
LIST OF ABBREVIATIONS......................................................................................................viii 
ABSTRACT.....................................................................................................................................x 
CHAPTER ONE: INTRODUCTION..............................................................................................1 
1.1 Epigenetics.....................................................................................................................1  
1.2 Genomic Imprinting.......................................................................................................2 
1.3 Paternally Expressed Gene 3.........................................................................................3 
1.4 Antisense Paternally Expressed Gene 3.........................................................................5 
1.5 References......................................................................................................................7 
CHAPTER TWO: TISSUE-SPECIFIC CONTRIBUTIONS OF PEG3 IN LACTATION AND 
MATERNAL CARE......................................................................................................................11 
2.1 Introduction..................................................................................................................11 
2.2 Materials and Methods.................................................................................................12 
2.3 Results..........................................................................................................................17  
2.4 Discussion....................................................................................................................34  
2.5 References....................................................................................................................38  
CHAPTER THREE: APEG3:  REGULATION OF PEG3 THROUGH AN EVOLUTIONARILY 
CONSERVED NCRNA................................................................................................................40   
3.1 Introduction..................................................................................................................40  
3.2 Materials and Methods.................................................................................................41  
3.3 Results..........................................................................................................................46  
3.4 Discussion....................................................................................................................56  
3.5 References....................................................................................................................59 
CHAPTER FOUR: SUMMARY AND FUTURE DIRECTIONS................................................61  
4.1 References....................................................................................................................71 
APPENDIX: PERMISSION TO INCLUDE PUBLISHED WORK.............................................72 
VITA..............................................................................................................................................73 
 
vi 
 
LIST OF TABLES 
3.1  Nucleotide Conservation of APeg3.......................................................................48 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
vii 
 
LIST OF FIGURES 
2.1  Breeding scheme for conditional knockouts .........................................................15 
2.2  Molecular characterization of Peg3FlpKO and Peg3DelKO mouse lines ...................18 
2.3  Growth effects of Peg3DelKO allele in neonates .....................................................21 
2.4 Peg3 conditional knockout pups:  impact on growth ............................................22 
2.5 Peg3 recombination in tissues correlated with growth and lactation 
phenotype...............................................................................................................23 
2.6 Peg3 conditional knockout dams:  impact on milk letdown .................................26 
2.7 Overnight lactation and nest-building experiment scheme....................................27 
2.8 Oxytocin-induced milk ejection in Nkx2.1-Cre dams...........................................29 
2.9 Peg3 conditional knockout mothers:  nest-building behavior................................30 
2.10 Raw nest-building data from dams with 5 dpp pups .............................................31 
2.11 Raw nest-building data from dams with 10 dpp pups ...........................................32 
2.12 Raw nest-building data from dams with 15 dpp pups ...........................................33 
3.1 Evolutionary conservation of APeg3 among placental mammals.........................47 
3.2 Predicted secondary structures of APeg3 mRNA .................................................50 
3.3 Effects of APeg3 overexpression on the transcription levels of Peg3...................52 
3.4 qRT-PCR amplifying larger portion of the Peg3 transcript...................................54 
3.5 Effects of APeg3 overexpression on the protein levels of PEG3..........................55 
4.1 Imprinting and neuroendocrine panel from 6-month old female brain and 1 dpp 
neonate head...........................................................................................................63 
4.2 Predicted Peg3 binding sites upstream of OxtR....................................................64 
4.3 Evidence and proposed role for Peg3 in vasopressin replenishment.....................70 
 
 
viii 
 
LIST OF ABBREVIATIONS 
Peg3   Paternally Expressed Gene 3 
APeg3   Antisense Paternally Expressed Gene 3  
Cre   Cre-recombinase 
MMTV  Mouse Mammary Tumor Virus 
Nkx2.1  NK2 Homeobox 1 
Zp3   Zona Pellucida Glycoprotein 3 
RNAi   RNA Interference 
PEG   Paternally Expressed Gene 
MEG   Maternally Expressed Gene 
CpG   Cytosine-phosphate-Guanine 
DMR   Differentially Methylated Region 
ICR   Imprinting Control Region 
P1   Postnatal Day 1 
P21   Postnatal Day 21 
EUCOMM  European Conditional Mouse Mutagenesis 
dpp   Day Post-partum 
PBS   Phosphate-buffered Saline 
qRT-PCR  Quantitative Reverse-Transcriptase Polymerase Chain Reaction 
TBS   Tris-buffered Saline 
Peg3CoKO  Peg3 Transcriptionally-truncated Allele 
Peg3FlpKO  Peg3 Recapitulated Allele 
Peg3DelKO  Peg3 Translationally-truncated Allele 
ORF   Open Reading Frame 
WT   Wild-type 
ix 
 
B6   C57BL/6J 
ANOVA  One-way Analysis of Variance 
T0   Time of Reintroduction 
'   Change 
TSS   Transcriptional Start Site 
MFE   Minimal Fold Energy 
DNA   Deoxyribonucleic Acid 
RNA   Ribonucleic Acid 
ncRNA  Non-coding RNA 
lncRNA  Long Non-coding RNA 
mRNA   Messenger RNA 
smRNA  Small RNA 
miRNA  Micro-RNA 
snoRNA  Small Nucleolar RNA 
piRNA   Piwi-interacting RNA 
siRNA   Small Interfering RNA 
OxtR   Oxytocin Receptor 
EMSA   Electrophoretic Mobility Shift Assay 
BS   Binding Site 
ChIP   Chromatin Immunoprecipitation 
IgG   Immunoglobin Gamma 
 
 
 
x 
 
ABSTRACT 
Genomic imprinting is characterized by the restrictive expression of a gene from one of the two 
inherited parental alleles.  Many of these genes have been implicated in neonatal growth and 
mammalian reproduction.  The two studies discussed in this dissertation focus on the tissue-
specific contributions of Paternally Expressed Gene 3 (Peg3) on lactation and maternal care as 
well as the regulation of this gene through an antisense RNA (APeg3).  In the first study, a 
conditional knockout allele has been developed to further characterize these known functions of 
Peg3 in a tissue-specific manner.  The mutant line was first crossed with germline Cre, 
producing a progeny that displayed growth retardation phenotypes consistent with previous 
reports.  The mutant line was then crossed individually with MMTV- and Nkx2.1-Cre lines to 
test  Peg3’s  roles  in  the  mammary  gland  and  hypothalamus,  respectively.    The results indicate 
that the milk letdown process was impaired in the nursing females with the Peg3 mutation in the 
mammary gland, but not in the hypothalamus.  In contrast, one of the maternal-caring behaviors, 
nest-building, was interrupted in the females with the mutation in both MMTV- and Nkx2.1-
driven lines.  Overall, this is the first study to introduce a conditional knockout allele of Peg3 
and to further dissect its contribution to mammalian reproduction in a tissue-specific manner.  
 
In the second study, we investigate the functions of APeg3, a gene that lies antisense of the Peg3 
3’-untranslated region, with comparative genomics and cell line-based approaches.  APeg3 
transcript displays a high degree of sequence conservation among placental mammals, but 
without any obvious open reading frame, suggesting APeg3 may have been selected as a ncRNA 
gene during eutherian evolution.  RNA secondary structure analyses also support a ncRNA 
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function.  The results from cell line-based transfection experiments demonstrate APeg3 has the 
potential to down-regulate the mRNA and protein levels of Peg3.  Overall, these results suggest 
that APeg3 has evolved as a ncRNA gene and controls the function of its sense gene Peg3.  
When combined, the two studies in this dissertation offer new insight into the regulation and 
function of the imprinted transcription factor Peg3.   
1 
 
CHAPTER ONE 
INTRODUCTION 
1.1 Epigenetics  
The beauty of our genome lies in its complexity.  Where computers are able to code in binary, a 
series  of  zero’s  and  one’s;;  our  genome  has  a  quaternary system,  as  A’s,  G’s,  C’s  and  T’s.      It  is  
incredible to think that the addition of two extra variables can give rise to the immense extra-
computational processes of individuals, such as the development of organ systems, logic and 
even thought.  In fact, it is impossible to describe the complexities found in nature when limited 
to the primary sequence of a stretch of DNA in a genome.  We know now that these extra 
dimensions of processing are due, in large part, to the coding that occurs just outside and around 
the DNA.  
 
Epigenetics is the study of heritable changes in gene expression that are not due to a change in 
the sequence of the DNA.  Epigenetics is fascinating because it has the power to explain the 
changes that occur during development, temporally and spatially, as well as the changes that are 
taken in as a result of environmental influences.  For example, any given mammal has two sets 
of each chromosome.  This is all the genetic information they are given from the beginning of 
their life, when a sperm fertilizes an egg.  The development of the hundreds of cell types that 
make up all the organ systems in the body cannot be explained by this inheritance alone.  To 
understand what regulates complexity of this magnitude, it was necessary to come up with an 
entirely new field, epigenetics (1).  
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When the term epigenetics was first used, the aim was to describe the interplay between the 
genetic content and the surrounding environment that gives rise to fully developed multicellular 
organisms.  Over the years this definition has been reshaped by the findings within the field to 
give rise to the definition scientists use today (2).  The dynamic landscape that surrounds and 
interacts with the DNA has the ability to be condensed into fundamental changes responsible for 
the considerable plasticity of the various cells in our body.   In fact, these epigenetic mechanisms 
can be broken down into three distinct layers of encoding that are responsible for the expression 
and repression of the information contained within the DNA:  DNA methylation, Histone 
modification and RNA interference (RNAi).   
 
1.2 Genomic Imprinting 
Diploid cells contain two copies of each autosomal chromosome, inheriting one from each 
parent.  If the two parental chromosomes are identical, transcription of genes from these 
chromosomes is also identical.  However, in mammals, there exists a subset of genes whose 
expression is allowed from only one of the two chromosomal copies and is dependent on which 
parent the allele is inherited from (3,4).  The nomenclature of these genes indicates their origin of 
expression.  Paternally-expressed genes (PEGs) are maternally silenced, owing expression solely 
to the paternal copy, while maternally-expressed genes (MEGs) are paternally silenced and are 
expressed from the maternal allele.  When these genes were discovered, it was understood that 
the  silenced  copy  of  these  genes  must  carry  a  mark,  or  “imprint”  with  them  in  the  germline  that  
is  transmitted  through  fertilization,  this  spawned  the  term  “Genomic  imprinting”  (5,6).   
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Genomic imprinting is a phenomenon which results in parent-of-origin specific monoallelic 
expression of a gene (7).  As such, these genes are functionally hemizygous, having no 
functional back-up copy on which to rely.  This results in a set of genes, which comprise less 
than 1% of the human genome, with a substantial susceptibility to genetic disorders (8).  Several 
of these genes have been implicated in the regulation of growth and prenatal development.     
 
As more imprinted genes were identified through nuclear transplantation studies, patterns in their 
location and regulation began to emerge.  First, most imprinted genes were found to be clustered 
within the genome.  Greater than 80% of imprinted genes are found near another imprinted gene. 
The human genome contains 16 of these imprinted clusters (9).  Second, the parent-of-origin 
specific repression of these genes was found to be dependent on DNA methylation at spans of 
Cytosine-phosphate-Guanines (CpGs) that are differentially methylated between the maternal 
and paternal copy.  The Differentially Methylated Regions (DMRs) that contain spans of CpGs, 
termed  “CpG  Islands”,  could  control  imprinting  of  the  entire  imprinted  cluster.    DMRs  that  were  
seen to have this function were termed Imprinting Control Regions (ICRs).  Finally, each 
imprinted domain was seen to contain at least one imprinted non-coding RNA.  In some 
instances, these imprinted ncRNAs have been implicated in the control of the whole imprinted 
domain (9,10)   
 
1.3 Paternally Expressed Gene 3  
Paternally Expressed Gene 3 (Peg3) is an imprinted gene located on human chromosome 
19q13.4, mouse chromosome 7qA1 and encodes a 12-finger kruppel-type zinc finger containing 
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protein (11,12) .  Peg3 has previously been localized to the nuclei of neuronal cells and has been 
shown to have DNA-binding capabilities (13,14).  This implicates Peg3 as a transcription factor 
and suggests that the expression of multiple target genes could change from a deficit in Peg3 
(15).  Peg3 expression is most dominant in the ovary, placenta and brain as observed in murine 
models (12,16).  PEG3 is conserved among placental mammals, and has been shown to be 
important for a range of processes in eutherians from tumor suppression in breast, ovarian and 
glial cancer to maternal-caring behavior (16,17,18,19) .  The inherent monoallelic expression of 
Peg3 makes this gene an easy target for the effects of deleterious mutations.  As a result, Peg3 
has been implicated in many diseases and phenotypes, highlighting the importance of PEG3 
expression to human health.  
     
The potential roles of Peg3 in disease have triggered the production of Peg3 mutant mouse lines 
which have been studied for multiple characteristics.  However, the most striking and consistent 
characteristics observed in a Peg3 mutant line is an inability for the mothers to take care of their 
young, as well as a growth defect in neonatal mice (19,20).   A more recent mouse line with a 
deletion in Peg3 promoter-region as well as a strain carrying a transcriptional truncation were 
reported to have similar effects in Peg3-deficient neonates by our group (15,21). Peg3-deficient 
neonates in these studies have shown a 10% deficit in growth at postnatal day 1 (P1) and up to a 
30% deficit in growth at P21 (15,20,21).  Furthermore, Peg3-deficient mothers have poor 
maternal-caring behavior which often results in a mortality rate of 80% in neonates (22).  While 
imprinted genes account for <1% of all transcriptional units, a disproportionate fraction of them, 
including Peg3, are involved in growth and prenatal development.  
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The effects of Peg3-deficient mothers have been linked to inadequate milk letdown as well as 
deficits in maternal-caring behaviors (22). However, the process of milk letdown is complex 
requiring a stimulus and response from both the neonate and the mother in multiple organs.  In 
response  to  a  baby  suckling  on  a  mother’s  teat,  the  hypothalamus  of  the  mother  is  triggered  to  
release oxytocin into the bloodstream.  Oxytocin then signals myoepithelial cells in the 
mammary gland to contract and then release milk through ducts in the teat (26).  It has been seen 
that oxytocin release in milk ejection has a pro social effect on the mother as well as a calming, 
analgesic-like effect on the pup tying the two systems together in synchrony and producing 
positive reinforcement cues for the mother as well as the offspring (27,28).  
 
The impacts of maternal-caring behavior in Peg3 mice have been linked closely to behaviors 
seen in Oxytocin-deficient mice described in previous literature, but have yet to be explained 
(30).  Furthermore, in Peg3-deficient mice, oxytocinergic neuron density is lower than Wild-type 
littermates (22).  This suggests Peg3 may be acting upstream of the neuropeptide, but does not 
specify the tissues in which Peg3 is necessary for proper milk letdown.  The studies also suggest 
Peg3 may be regulating oxytocin, but do not propose a molecular model for this hypothesis.   
 
1.4 Antisense Paternally Expressed Gene 3  
Recent progresses in high-throughput sequencing has allowed for the rapid advancement of 
many consortiums, such as ENCODE, to harvest massive amounts of data pertaining to human 
genomic and transcriptomic profiles.  The ENCODE project was able to detect an average of 
three transcripts for every one of the ~25,000 genes found in the human genome.  Antisense 
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RNAs are well known for their ability to silence the expression of the sense counterpart, either 
through transcriptional inhibition or post-transcriptional inhibition of the sense transcript (30).  
One of the most plausible theories of antisense gene function is their use in transcriptional 
regulation of their corresponding sense mRNAs through transcriptional interference (31).  
However, antisense genes can also function in post-transcriptional regulation through RNA 
degradation, RNA-initiated transcriptional suppression and translational inhibition.  Each 
mechanism could be acting through its own complex inter-regulatory network.  Although many 
of these genes have been identified through transcriptional profiling, the function of each of 
these genes has yet to be characterized.  
 
Imprinted non-coding RNAs are one of the most uncharacterized subsets of genes in the 
mammalian genome.  Many of these genes are shown to be required for regulatory maintenance 
of entire imprinted gene clusters and have strong implications in neuroendocrine function (10, 
32).  APeg3, an imprinted gene lying antisense of Peg3, has been identified as one of the major 
genes up-regulated in response to hyperosmotic stress in vasopressinergic neurons of the 
hypothalamus (33,34,35).  This implicates the gene in such functions as regulation of blood 
pressure and bodily fluid retention.  However, the function of APeg3 on a cellular level has yet 
to be revealed.   
 
In the following studies, we characterize the regulation of Peg3 by APeg3 as well as the tissue-
specific functions of Peg3.  The first of the following studies utilizes Peg3 mutant mice and 
suggests that Peg3 serves specific roles in different tissues, each centered on the aspect of 
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offspring growth and development. The second study uses comparative genomics and molecular 
techniques to investigate the functional role of APeg3 and show its potential to downregulate 
Peg3 expression in neuronal cells.  When combined, the studies illustrate the complex regulation 
and function of the imprinted transcription factor Peg3.    
 
The notable results and contributions presented in this work are: 1) The generation and 
characterization of a Peg3 conditional knockout mouse line, which is defective in PEG3 
expression at the protein level; 2) The examination of the tissue-specific functions of Peg3; 3) 
The implication of these tissue-specific functions for maternal care and reproduction;  4) The 
molecular link between Peg3 cellular function and the phenotype observed through binding and 
regulation of oxytocin receptor; 5) The cell-type specific regulation of Peg3 through the non-
coding RNA, APeg3;  6) The potential impact of regions containing conserved secondary 
structures in APeg3 on the regulation of Peg3. 
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CHAPTER TWO 
TISSUE-SPECIFIC CONTRIBUTIONS OF PEG3 IN LACTATION AND MATERNAL 
CARE 
 
2.1 Introduction 
Paternally Expressed Gene 3 (Peg3) is an imprinted gene located on human chromosome 
19q13.4 and mouse chromosome 7qA1 (1,2).  Peg3 encodes a protein with DNA-binding 
capabilities that is localized to the nucleus of neuronal cells (3,4).  Expression of Peg3 is most 
dominant in the ovary, placenta and hypothalamus as observed in murine models (2,5).  The 
potential roles of Peg3 in diseases ranging from low birth-weight to breast and cervical cancer 
have triggered the production of mutant mouse lines, which have been studied for multiple 
characteristics.  The most striking and consistent characteristics observed in a previous Peg3 
knock-in line is a maternal caring problem in Peg3-deficient dams and a growth defect in 
neonatal pups (6,7,8).  More recently, our group has generated a mouse line with a deletion in the 
promoter region as well as a strain carrying a transcriptional truncation, which were both 
reported to have similar effects (9,10). 
 
Peg3-deficient dams have been linked to inadequate milk letdown as well as problems with 
maternal-caring behaviors (7).  However, the process of milk letdown is complex, requiring a 
stimulus and response from both the neonate and the mother in multiple organs.  In response to a 
pup suckling on a dam's teat, the hypothalamus of the dam is triggered to release oxytocin into 
the bloodstream.  Oxytocin then signals myoepithelial cells of the mammary gland to contract, 
releasing milk through ducts in the teat (11).  It has been shown that oxytocin release in milk 
ejection has a pro-social effect on the dam as well as a calming effect on the pup, tying the two 
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systems in synchrony and producing positive reinforcement cues for the mother as well as the 
offspring (6,10). 
 
The neonatal growth, lactation and maternal care effects observed in Peg3 mutant mouse lines 
are similar to the effects seen in oxytocin and oxytocin receptor-deficient mice in previous 
literature (13,14,15).  Furthermore, in Peg3-deficient mice, oxytocin neuron density is lower than 
wild-type littermates (7).  This suggests that Peg3 may be acting upstream of the neuropeptide or 
the receptor.   However, the neuropeptide/receptor interplay between organ systems is a circuit.  
Often, the shutdown of a single component in the system results in a more dramatic effect than 
shutting down the entire system.  In that regard, we wanted to test the individual tissues 
responsible for the phenotypes observed in Peg3-deficient mice.  To narrow down the systems 
responsible for the developmental, physiological and behavioral roles of Peg3, we generated and 
characterized a line that allows for conditional deletion of the gene in vivo.  Using this 
conditional knockout line, we deleted Peg3 in the hypothalamus and mammary gland to observe 
defects in neonatal growth, lactation and maternal care.   
 
2.2 Materials and Methods 
2.2.1 Generation of Peg3FlpKO and Peg3DelKO strains 
The Peg3CoKO strain has been generated using a targeted ES cell, Peg3tm1a (EUCOMM) Hmgu, from the 
EUCOMM (European Conditional Mouse Mutagenesis) consortium, and has been maintained in 
the lab through maternal transmission for multiple generations (10).  The Peg3FlpKO line has been 
derived by crossing Peg3CoKO with the commercially available Rosa26-FLP line (Jackson Lab, 
Stock No. 009086, B6.129S4-Gt (ROSA)26Sortm1(FLP1)Dym/RainJ).  Progeny were tested for the 
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excision  of  β-Galactosidase and Neomycin resistance markers by PCR using the set of the 
following primers: Peg3-5ARM  (5’-CCCTCAGCAGAGCTGTTTCCTGCC-3’)  and  Peg3-
3ARM  (5’-AAGCTACCTGGGAAATGAGTGTGG-3’).    These  generated  mice were further 
screened to remove the Rosa26 Flippase allele by PCR using the following set of primers: NEW-
ROSA26-FlippaseF  (5’-TAAGTGAGGGTGAAAGCATCTGGG-3’)  and  NEW-ROSA26 
FlippaseR(5’-ACTCGTTTTAGGACTGGTTCAGA-3’).    The  identified  mice  heterozygous  for  
the Peg3FlpKO allele without the ROSA26-Flippase allele have been maintained with the mutant 
allele being transmitted as a maternal allele.  This Peg3FlpKO line has been maintained through 
backcrossing with the C57BL/6J strain for greater than 5 generations.  For conditional knockout 
experiments, the Peg3FlpKO mouse line was then crossed with commercially available MMTV-
Cre  (Stock # 003553, B6129-Tgn(MMTV-Cre)4Mam-LineD) and Nkx2.1-Cre (Stock # 008661 
C57BL/6J-Tg(Nkx2-1-cre)2Sand/J) lines from Jackson lab (18,19).  MMTV-Cre line D was used 
for its restricted expression in the brain (<10% recombination) and its inability to affect 
mammary development (20).  Primers used to test recombination in tissues from the conditional 
knockout breeding are: Pre-LoxF(5’-TGGACTTGGGAGATACTGTATTTATCAGCA-3’),  
LoxR1(5’-TGCCTTCTCTTTAGAGTGACTGAGG-3’)  and  PostLoxR2  
(TCTGACTTCCTGGGAGCCAGTAAGA-3’). 
 
The Peg3DelKO line has been derived through the crossing of female Peg3WT/FlpKO with male Zp3-
Cre (Jackson Lab, Stock No. 003651, C57BL/6-Tg (Zp3-cre) 93Knw/J).  Female heterogygous 
for the Peg3DelKO allele were screened with the following set of primers: Peg3-5ARM and Peg3-
LoxR  (5’- TGAACTGATGGCGAGCTCAGACC-3’).    These  F1  mice  were  further  tested  for  the  
absence of the Cre recombinase cassette by PCR with the following set of primers: Zp3-CreF 
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(5’-TAGGAATCACGTGGAGTGTCT-3’)  and  oIMR1085  (5’-
GTGAAACAGCATTGCTGTCACTT-3’).    This  Peg3DelKO line was similarly backcrossed with 
male C57BL/6J for greater than 4 generations.  These mice were then used for testing the 
neonatal growth experiments.  For genotyping, ear snips were incubated overnight in the lysis 
buffer (50 mM Tris-Cl at pH 8.0, 100 mM EDTA at pH 8.0, 250 mM NaCl, 1% SDS, along with 
20  μg/mL  Proteinase  K)  at  65oC.  The 60-fold diluents of these lysed samples were used as a 
template for PCR amplification using the PCR premix kit (iNtRON Biotech) at the following 
conditions (Step 1, 95°C-30 sec; Step 2, 95°C-30 sec, 60°C-30 sec, 72°C-60 sec for 35 cycles; 
Step 3, 72°C-10 min).   
 
2.2.2 Milk retention and maternal care experiments 
As displayed in the conditional knockout breeding scheme (Figure 2.1), four different types of 
females were bred with male B6 to observe maternal care and lactation phenotypes. Beginning 
one hour after the start of the dark cycle, dams, their litters and bedding material were weighed 
and pups were separated from their dams.  Pup/mother separation lasted for 2 hours and was 
followed by weight measurements of the same materials and a reintroduction to the mother.  
Every two hours after reintroduction to the mothers, their litters and bedding material were 
monitored for weight gain/loss as well as whether or not the mother was crouching over the pups 
at the time of observation.  This experimental setup was tested on 2 litters for each dam (5 Nkx-
Cre/Wt, 5 Nkx-Cre/FlpKO, 7 MMTV-Cre/Wt, 7 MMTV-Cre/FlpKO) at three different time 
points (5 dpp, 10 dpp, and 15 dpp).  To measure the amount of nutrient transfer from the dams to 
the pups, we subtracted the amount of weight gain/loss of the litter from the amount of gain/loss 
of the dam every two hours.   
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Figure 2.1.  Breeding scheme for conditional knockouts.  (Cross A) Peg3FlpKO males were 
crossed with Nkx2.1-Cre females to produce offspring with paternally-transmitted deletions of 
Peg3.  These pups were tested for lethality and growth defects that resulted in Figure 2.4.  
Female Nkx2.1-Cre/WT and Nkx2.1-Cre/FlpKO from these experiments were then used for 
(Cross B), where they were bred with B6 males to be used for testing lactation and maternal 
caring behaviors.  A similar breeding scheme was used for (Cross C) and (Cross D). However, 
MMTV-Cre females in (Cross C) were available as MMTV-Cretg/tg, which allowed for a simpler 
breeding scheme. 
 
The nest-building behavior was monitored with a modified protocol20.  Modifications to the 
original protocol are as follows: 1) The weight of the untorn bedding material was measured 
every two hours to determine the dams with exceptional nest-building behavior. 2) The time 
course was extended from 30 minutes to 14 hours to account for any dams with slow nest-
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building behavior. 3) The nest-building behavior was tested at three developmental stages: 5 dpp, 
10 dpp and 15 dpp. 
 
2.2.3 Mammary oxytocin response experiments 
Oxytocin response experiments were completed using the modified protocol21.  We determined 
the optimal period of latency for the Nkx2.1-Cre mice to be 40 minutes, and for the MMTV-Cre 
mice to be 20 minutes to build up milk.  Following CO2-mediated sacrifice of the conditional 
knockout and wild-type dams, mammary glands were exposed.  Pictures of the mammary glands 
were taken prior to addition of any solutions.  Phosphate-buffered saline (PBS) was added to 
both sides of the mouse mammary glands, then syphoned off and the mammary glands were 
imaged.  Then, Oxytocin (Sigma Cat No O4375), re-suspended in 1x PBS at a concentration of 1 
mg/mL, was added to the mammary gland and allowed to incubate for 1 minute before the 
solution was syphoned off.  The mammary gland was then imaged.  This protocol was performed 
for three of each conditional knockout and corresponding WT littermates.   
 
2.2.4 cDNA synthesis and Reverse-Transcription PCR (RT-PCR) 
Total RNA was isolated from mouse organs using Trizol (Life Technologies Cat No 10296028) 
according to the manufacturer’s  protocol.    The  isolated  RNA  was  first  reverse-transcribed using 
the M-MLVRT First-Strand Synthesis System (Invitrogen Cat No. 28025-013) in accordance 
with  manufacturer’s  protocol  with  random  hexamer  and  oligo-dT primers.  Subsequent cDNA 
was used as a template for RT-PCR.  All RT-PCR reactions were carried out for 33 cycles under 
standard PCR conditions.  The primers for Peg3 and β-Actin were as follows: Peg3-RT-Exon3F2 
(5’-ATCCCTGAAACGCTCAAGCCCT-3’),  Peg3-Ex7R  (5’-
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CTCCAGGTTGTCCTGAATTGGA-3’),  βactin-RT1a  (5’-
GAGCACCCTGTGCTGCTCACCGA-3’)  and  βactin-RT1b  (5’- 
CTCTTTGATGTCACGCACGATTTC-3’). 
 
2.2.5 Protein isolations and western blots 
Mice were sacrificed by cervical dislocation in accordance with Institutional Animal Care and 
Use Committee (IUCAC) guidelines. Whole heads were harvested and immediately 
homogenized in lysis buffer (0.25M Tris–HCl, pH 7.8, plus 0.1% NP-40) with Proteinase 
Inhibitor Cocktail (EMD-Millipore Cat No 539131) at 1x concentration. The cellular debris was 
removed by centrifugation for 10 minutes at 4°C.  Protein concentrations were determined by the 
Bradford assay kit (Pierce), using diluted BSA as protein standards.  Sixty micrograms of each 
lysate were separated on 10% SDS–PAGE gels and transferred to PVDF membranes (Hybond-P, 
Amersham) using a Mini Trans-Blot wet transfer cell (Bio-Rad).  Membranes were blocked for 1 
hour in the Tris-buffered saline (TBS) containing 1% skim milk and 0.05% Tween 20, and 
incubated overnight at 4°C with a custom-made purified anti-PEG3 antibody (10).  These blots 
were incubated for an additional 1 hour with the secondary antibody linked to horseradish 
peroxidase (Sigma Cat No A6154).  The blots were developed using the Western blot detection 
system  according  to  the  manufacturer’s  protocol  (Thermo  Scientific  Cat  No  17295).     
 
2.3 Results 
2.3.1 Molecular characterization of Peg3FlpKO and Peg3DelKO mouse lines 
In order to test when and where Peg3 expression is required for proper growth and development, 
two new mouse lines have been generated, Peg3FlpKO and Peg3DelKO  (Figure 2.2, a.).   
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Figure 2.2.  Molecular characterization of Peg3FlpKO and Peg3DelKO mouse lines. (a) Schematic 
representation of Peg3 alleles.  Arrows above each allele indicate transcriptional direction and 
length.  Exons  are  indicated  by  boxes,  with  Exon  6  denoted  as  a  white  “6”.    Flippase  recognition  
target (FRT) sites are shown as green triangles.  LoxP sites are indicated by red triangles.  In the 
Peg3CoKO allele, we inserted a cassette containing a splice acceptor (SA) sequence, an internal 
ribosomal  entry  site  (IRES)  and  a  β-Galactosidase  (β-Gal) reporter gene, followed by a poly-
adenylation signal (pA).  Neomycin Resistance gene (NeoR) is followed by another pA.  
Crossing Peg3CoKO mice with a Flp-expressing line results in the Peg3FlpKO allele.  Successive 
crossing of Peg3FlpKO mice with Cre-expressing lines results in the Peg3DelKO allele.  (b) RT-PCR 
of Peg3 from various tissues in Peg3FlpKO line.    β-Actin was used as an internal control.  (c) RT-
PCR of Peg3 from various tissues in Peg3DelKO.  Cre-mediated recombination of Exon 6 results 
in the smaller amplicon size (346 bp in length) as compared to the wild-type product (453 bp in 
length).  (d) Western blots from the 1-day-old heads of Peg3DelKO. To visualize expression of 
PEG3  protein,  western  blots  were  probed  for  Peg3,  stripped  and  then  probed  for  β-Actin.  
 
 
The first line was generated by recombination of a knock-in allele (Peg3CoKO) of Peg3 by Flp 
recombinase (10).  Upon recombination, two poly-adenylation sites were excised, recovering the 
full-length transcription of Peg3 (Peg3FlpKO).  In this line, Exon 6 is flanked by two LoxP sites. 
This results in a conditional knockout-ready line, which can be bred with Cre-recombinase-
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expressing (Cre) lines to produce a deletion of Exon 6.  The deletion of Exon 6 generates the 
second mouse line, Peg3DelKO (Figure 2.2, a.).  This deletion causes a frameshift and subsequent 
translational truncation of the Peg3 ORF (Open Reading Frame), which starts at Exon 3 and ends 
at Exon 9.  We used three Cre-expressing lines in this study (Zp3-Cre, MMTV-Cre and Nkx2.1-
Cre).  Zp3-Cre was used to make the Peg3DelKO line through germline recombination, whereas 
MMTV and Nkx2.1-Cre were used for the tissue-specific deletion of Exon 6 in Peg3.  
 
Proper splicing in the Peg3FlpKO line was first tested with RT-PCR using the total RNA isolated 
from the brain, testes and heart of the wild-type (WT) and heterozygote (FlpKO) mice carrying 
the mutant allele paternally (Figure 2.2, b.).  The results indicated no abnormal splicing between 
exons 3-7 of the Peg3FlpKO line based on detection of the same-size product (453 bp in length) 
between the WT and FlpKO samples (Figure 2.2, b.).  Furthermore, a series of RT-PCR testing 
the different parts of the 9.0-kb transcript of Peg3 also confirmed the full-length transcription of 
Peg3 in the Peg3FlpKO line (data not shown).  In the Peg3DelKO line, the proper expression of Peg3 
transcript lacking Exon 6 was also tested by RT-PCR in a similar scheme as the Peg3FlpKO line 
(Figure 2.2, c.).  According to the results, RT-PCR generated the expected 346-bp product from 
the multiple tissues of Peg3DelKO line, which is lacking the 107-bp-long Exon 6.  On the other 
hand, the same PCR generated the 453-bp product from WT tissues.  However, the brain and 
testes also produced additional products besides the 346-bp products.  In the case of testis, the 
upper band (453 bp) corresponds to the product from the maternal allele due to its derepression 
in germ cells.  In the case of the brain, sequencing of the 410-bp minor product revealed the 
presence of a small exon, 64 bp in length, between Exons 4 and 5. More detailed analysis with 
the total RNA from WT confirmed that this is a minor exon that was previously undetected but 
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usually included as part of the normal transcript of Peg3 (data not shown).  Proper protein 
expression in the Peg3DelKO line was tested by western blot using the protein extracts from the 
brains of one-day-old pups.  The results indicated a complete abrogation of the protein PEG3, 
confirming that the deletion of Exon 6 causes the frameshift and subsequent truncation in the 
ORF of Peg3 (Figure 2.2, d.).  Taken together, these results confirm the successful generation of 
the Peg3FlpKO and Peg3DelKO mouse lines.  Since the Cre lines used for the current study have the 
mixed background of C57BL/6J (B6) and 129/SvJ, the females from the Peg3FlpKO and Peg3DelKO 
lines have been backcrossed with B6 males for two years, thus deriving these lines with the 
relatively pure B6 background. 
 
 
2.3.2 Growth retardation in Peg3DelKO pups 
To examine whether the Peg3DelKO line also displayed growth effects consistent with the previous 
studies (7,9,10), we performed breeding experiments measuring body weights at two different 
time points: 1 and 21 days postpartum (dpp).  In these experiments, we crossed male 
Peg3DelKO/WT with C57BL/6J females.  Their progeny were weighed and genotyped.  Their 
whole-body weights were then converted into a percentile relative to the average weight of the 
litter.  According to the results, at 1 dpp (Figure 2.3, a.), the average litter size was 8.5, which is 
smaller than that of B6 mice (~10).  The ratio between the heterozygous Peg3WT/DelKO and 
Peg3WT/WT was 0.795:1, and did not vary significantly from the expected mendelian ratio 
(P=0.3390).  These results suggest that Peg3WT/DelKO mice had not been selected against during 
fertilization or during embryogenesis.  The breeding results at 21 dpp (weaning age) also derived 
similar outcomes (Figure 2.3, b.).  The average litter size was 9.0 and the transmission ratio was 
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also similar to the mendelian ratio (Peg3WT/WT:Peg3WT/DelKO = 0.85:1), again indicating that no 
selection had occurred against the Peg3WT/DelKO pups during the postnatal stages (p=0.5287). 
 
Figure 2.3.  Growth effects of Peg3DelKO allele in neonates.   (a) Male Peg3DelKO/WT were bred 
with female wild-type littermates to generate Peg3WT/DelKO pups with the paternal transmission of 
the mutant allele.  Pups were genotyped and weighed at 1 day postpartum (dpp), then compared 
to the average weight of the litter.  The number of pups belonging to each percentile weight 
range was then graphed to visualize the weight distribution of Peg3DelKO pups in comparison to 
their wild-type littermates.  (b) The same series of analyses were repeated with the pups at the 
weaning age (21 dpp). (c) and (d) display representative wild-type (WT) and Peg3DelKO 
littermates exhibiting weight differences.  
 
Although significant levels of lethality were not observed in the Peg3WT/DelKO pups, major growth 
retardation was observed at both 1- and 21-dpp time points (Figure 2.3, a. b.).  At 1 dpp, the 
average weight difference was 6.99% between Peg3WT/DelKO pups and their WT littermates 
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(p=0.0028).  A more dramatic growth effect was observed at 21 dpp, which displayed 20% 
weight difference between Peg3WT/DelKO pups and their WT littermates (p=0.0001).  Taken 
together, these results confirm the critical role of Peg3 in controlling growth rates.  The results 
also highlight a more significant role of Peg3 during postnatal stages than during gestation in the 
newly derived Peg3WT/DelKO mutant line.   
 
2.3.3 Peg3 conditional knockout pups:  growth effects 
The floxed allele Peg3WT/FlpKO was  crossed  with  two  Cre  lines  to  test  Peg3’s  tissue-specific roles 
in controlling growth rates (Figure 2.4).   
 
Figure 2.4.  Peg3 conditional knockout pups: impact on growth.  Pups with conditional Peg3 
knockouts were weighed and compared to the average weight within the litter.  Percentile 
weights within litter were then separated into 10% ranges.  The numbers of pups in each 
percentile range are shown for MMTV-driven deletion at 1 dpp (a) and 21 dpp (b) and for 
Nkx2.1-driven deletion at 1 dpp (c) and 21 dpp (d). 
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MMTV-Cre and Nkx2.1-Cre lines were employed to abolish Peg3 expression in the mammary 
gland and hypothalamus, respectively.  Recombination in these target organs was verified by 
PCR with primers flanking the inserted cassette (Figure 2.5).   
 
Figure 2.5.  Peg3 recombination in tissues correlated with growth and lactation phenotype.  
Genomic DNA was isolated from tissues known to have high expression of Peg3 and have 
implications in reproduction.  Mammary and hypothalamus were isolated from dams who 
inherited the Peg3FlpKO allele, along with the conditionally-expressing Cre line indicated. 
Placentas were isolated from earlier experiments, wherein the embryos inherited the Peg3FlpKO 
allele and the MMTV-driven Cre allele.  The Peg3FlpKO and Peg3DelKO alleles were amplified 
from the mammary and placenta using (5-ARM, LoxR primers) and are indicated by the red 
labels with arrows (a,b).  M-T indicates the top mammary gland from a mouse, while M-B 
distinguishes the bottom mammary gland.   Hypothalamic regions were amplified using 
(PreLoxF, LoxR1 and PostLoxR2 primers) which display the Peg3WT,Peg3FlpKO and Peg3DelKO 
alleles. 
 
This series of breeding experiments were also analyzed in a similar manner as the Peg3DelKO line 
(described above), measuring the average litter size and body weights.  For simplicity, the 
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genotypes of the pups were abbreviated in the following manner:  MMTV-Cretg/+ ; Peg3WT/FlpKO 
as MMTV-Cre/FlpKO and MMTV-Cretg/+ ; Peg3WT/WT as MMTV-Cre/WT. 
 
 
The breeding of male Peg3FlpKO/WT with female MMTV-Cretg/tg yielded the following results:  At 
1 dpp, the average litter size was 7.4 (59 pups/8 litters), which was slightly smaller than 
expected.  The ratio between MMTV-Cre/WT and MMTV-Cre/FlpKO (39:20) deviated 
significantly from the expected mendelian ratio (1:1), suggesting that potential embryonic 
lethality is associated with MMTV-Cre/FlpKO pups (p=0.0134).  This embryonic lethality may 
be attributed to the small first litter size in MMTV-Cre mothers or expression of MMTV-Cre in 
the embryo-driven placenta (Figure 2.5).  At 21 dpp, the average litter size was 6.8 (34 pups/5 
litters) and the ratio of MMTV-Cre/WT and MMTV-Cre/FlpKO (16:18) was close to the 
mendelian ratio (p=0.7317).  This indicates that no obvious lethality is associated with the 
MMTV-Cre/FlpKO pups at the 21-dpp time point.  The weight profiles also show no major 
difference between MMTV-Cre/WT and MMTV-Cre/FlpKO at both 1 and 21-dpp time points 
(p=0.1615 for 1 dpp and p=0.5997; Figure 2.4, a. and Figure 2.4, b.).  This suggests that MMTV-
driven deletion of Peg3 alone may not have any major impact on growth rates of the pups during 
gestation and also during postnatal stages.  
 
The second set of breeding experiments were performed through crossing male Peg3FlpKO/WT 
with female Nkx2.1-Cre+/tg.  The litter sizes at both 1 and 21-dpp time points were overall 
normal:  8 at 1 dpp and 7.8 at 21 dpp.  The ratios of the pups with 4 genotypes were also close to 
the mendelian ratio of two independently segregating heterozygous loci (1:1:1:1) (p=0.7698 for 1 
25 
 
dpp and p=0.0649 for 21 dpp).  The actual ratios for these breedings are shown in Figure 2.4, c. 
and 2.4, d.  This indicated no obvious lethality in the Nkx2.1-Cre/FlpKO pups from this breeding 
experiment.  The weight profiles for the pups with these four genotypes also displayed no 
statistically significant variance at both time points, based on the one-way analysis of variance 
(ANOVA) (p=0.593639 for 1 dpp and p=-0.643121 for 21 dpp).  Collectively, the results from 
the two sets of breeding experiments concluded that MMTV-driven (mammary-specific) deletion 
of Peg3 may produce lethality when litter size is constrained (as in MMTV-Cre first litters), but 
did not result in lethality from later litters.  Also, MMTV-driven Peg3 deletion did not affect 
growth rates.  Our results also show Nkx2.1-driven (hypothalamus-specific) deletion of Peg3 did 
not have any significant impact on survival and growth rates of the animals during gestation and 
postnatal stages. 
   
2.3.4 Peg3 conditional knockout dams:  milk letdown 
One of the mutant phenotypes associated with Peg3 is a defect in milk letdown in nursing 
females (7,10). This particular phenotype was detected among the females of the new mutant line 
Peg3WT/DelKO (data not shown).  Four sets of females derived from the previous breeding 
experiments were further utilized to test this mutant phenotype of Peg3.  This series of analyses 
used 7 MMTV-Cre/FlpKO, 7 MMTV-Cre/WT, 5 Nkx2.1-Cre/FlpKO and 5 Nkx2.1-Cre/WT 
mice.  The test was performed in the following manner.  The efficient milk letdown process by 
nursing females was evaluated through measuring weight (milk) transfer from nursing females to 
pups (Figure 2.6, a. and 2.6, b.).   
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Figure 2.6.  Peg3 conditional knockout dams: impact on milk letdown.  Milk retention at 10 dpp 
of MMTV-driven (a) and Nkx2.1-driven (b) deletions in Peg3 are shown as a function of the 
weight change between every two hours in the dam subtracted by the weight change between the 
same time points in the pups.  Therefore, the weight flux shown is a measure of how much 
nutrient transfer is occurring from the dam to her pups at each given time interval with positive 
slopes indicating weight gain in the dam that is not transferred over to the pups.  Conversely, 
negative slopes indicate a dam giving all her mass to the pups, without gaining any weight 
herself.  Blue lines indicate individuals inheriting the wild type allele for Peg3 and Red lines 
indicate dams who have inherited the FlpKO allele The dashed black box indicates the critical 
point wherein reintroduction of the dams to their pups has just occurred.  (c) Oxytocin-induced 
milk ejection was surveyed in MMTV-driven Peg3 deleted mice alongside wild-type littermate 
controls.  Black arrows indicate ductal branches in the mammary gland.   
 
 
A nursing female was first separated from her litter for two hours, and then reintroduced to her 
pups.  From the reintroduction (T0), the weights of the female and the litter were individually 
measured every two hours (Figure 2.7).   
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Figure 2.7.  Overnight lactation and nest-building experiment scheme.  This cartoon displays the 
overall schematic for milk provision and nest-building behavior experiments.  
 
 
During every two-hour period, the weight change of the female (' Dam weight) was further 
subtracted by that of the litter (' Litter weight).  For each female, a series of these subtracted 
weight values were summarized as a line graph to indicate the trend of the weight fluctuation.  
As shown in Figure 2.6, a., the largest surge of weight (milk) transfer occurred during the 
Reintroduction to T+4 time period in the majority of the wild-type females (7 MMTV-Cre/WT, 
blue line).  This is visualized by the blue lines with negative slope, indicating that the 
accumulated weight of nursing females was transferred to the weight of their litters.  On the 
other hand, all of the mutant females (7 MMTV-Cre/FlpKO, red line) displayed positive slopes, 
indicating that the accumulated weight of the nursing females were not efficiently transferred to 
their pups during this time period.  This indicated that the mutant females lacking Peg3 
expression in the mammary gland most likely have a problem in releasing milk to their pups.  
28 
 
This series of experiments was repeated with two litters for each female, and also performed at 
three different time points, at 5, 10, 15 dpp.  Overall, the outcomes were consistent and 
reproducible among the different experiments.  The results from the experiment at 10 dpp are 
shown as a representative set (Figure 2.6, a.). 
 
This series of experiments was also performed with another set of females (Nkx2.1-Cre/WT and 
Nkx2.1-Cre/FlpKO, Figure 2.6, b.).  The results did not show any major difference between the 
two groups of females, indicating that the deletion of Peg3 in the hypothalamus did not have any 
definitive impact on the weight (milk) transfer.  To follow up on the results derived from these 
two series of experiments, we also performed an independent series of experiments testing the 
response of the mammary gland to the hormone oxytocin.  For these experiments, three females 
from each of the four groups (MMTV-Cre/WT, MMTV-Cre/FlpKO, Nkx2.1-Cre/WT, Nkx2.1-
Cre/FlpKO) were sacrificed, and their mammary glands were exposed to a high concentration of 
oxytocin 1 mg/mL (10x physiological concentration) (Figure 2.6, c.).  The milk flow through the 
mammary ducts was easily detected among the MMTV-Cre/WT females.  In contrast, the milk 
efflux was not obvious among the 3 MMTV-Cre/FlpKO females tested, indicating that the 
mammary gland without Peg3 expression is not responsive to the high dose of oxytocin.  This 
further suggests potential defects in the oxytocin circuitry as a main cause for the observed 
defect in the milk letdown process.  We also performed the same series of oxytocin-induced milk 
ejection experiments with the set of Nkx2.1-Cre/WT and Nkx2.1-Cre/FlpKO (Figure 2.8).   
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Figure 2.8.  Oxytocin-induced milk ejection in Nkx2.1-Cre dams.  Similar to the experiment 
observed in Figure 2.6c, 1 mg/mL oxytocin in 1x PBS was dripped onto the mammary glands of 
an Nkx2.1-Cre/FlpKO dam and WT littermate.  Mammary glands were then visualized for 
movement of milk through the mammary ducts. 
 
 
However, in the Nkx2.1-Cre lines, there was no observable difference in milk flow between the 
wild type and conditional knockout females.  This set of results is also consistent with the results 
derived from the weight transfer experiments described above, showing the defects only among 
the females with the deletion of Peg3 in the mammary gland.  In summary, the results 
demonstrated that conditional knockout of Peg3 in the mammary gland causes a major defect in 
the milk letdown process, most likely through affecting the oxytocin circuitry.  It is also 
important to note that this defect is more readily detectable through mutating Peg3 in the 
mammary gland than in the hypothalamus.  
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2.3.5 Peg3 conditional knockout dams:  nest building 
While performing the weight transfer experiments, we also observed one behavioral abnormality 
that differentiated the wild type and mutant females, nest-building behavior.  Nursing females 
usually tear apart solid bedding materials and build nests to provide insulation for their pups.  
However, both mutant types, MMTV-Cre/FlpKO and Nkx2.1-Cre/FlpKO, were found to be 
inefficient at nest building (Figure 2.9, a.).   
 
 
Figure 2.9.  Peg3 conditional knockout mothers: nest-building behavior.  (a) Representative 
conditional knockout dams and wild-type littermates highlight differences observed in the nest-
building behavior.  (b) A graph shows the number of dams marked as good, mediocre and bad at 
building nests for  their  litters.    “Good”  dams  are  those  who  tore  100%  of  bedding  material  by  14  
hours.    “Mediocre”  dams  were  able  to  use  some,  but  not  all  of  the  bedding  material  by  14  hours.    
“Bad”  dams  are  those  that  display  no  interest  in  tearing  up  the  bedding  material to insulate their 
pups. 
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To systematically quantify this behavioral defect, we measured the weight of the untorn bedding 
materials every two hours.  The relative weight of the remaining material to the initial weight 
was used to measure the efficiency of the nest-building behavior.  The nursing females were 
further ranked from the best to worst nest builder based on their performance, which was judged 
by the relative weight of the remaining bedding materials (Figure 2.9, b., Figure 2.10, Figure 
2.11 and Figure 2.12).   
 
 
 
Figure 2.10. Raw nest-building data from dams with 5 dpp pups. The table displays the percent 
of the original bedding material that was still left at each time point from all four genotypes 
tested (MMTV-Cre/WT, MMTV-Cre/FlpKO, Nkx2.1-Cre/WT, Nkx2.1-Cre/FlpKO). Dams with 
WT genotypes are in black, while dams harboring the FlpKO allele are in Red.  Red dashed lines 
indicate  borders  used  to  separate  the  “Good”,  “Mediocre”  and “Bad”  nesting  behaviors  in  Figure 
2.9, b.  >100% bedding material remaining indicates the addition of weight to the bedding 
material by the dam, in most cases by the addition of water.  
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According to the results, a large fraction of both mutant females, MMTV-Cre/FlpKO and 
Nkx2.1-Cre/FlpKO, were consistently ranked at the bottom of the list, thus making up the 
majority of the worst nest builders (Figure 2.9, b., Figure 2.10, Figure 2.11 and Figure 2.12).   
 
 
Figure 2.11. Raw nest-building data from dams with 10 dpp pups. The table displays the percent 
of the original bedding material that was still left at each time point from all four genotypes 
tested (MMTV-Cre/WT, MMTV-Cre/FlpKO, Nkx2.1-Cre/WT, Nkx2.1-Cre/FlpKO). Dams with 
WT genotypes are in black, while dams harboring the FlpKO allele are in Red.  Red dashed lines 
indicate  borders  used  to  separate  the  “Good”,  “Mediocre”  and “Bad”  nesting  behaviors  in  Figure 
2.9, b. >100% bedding material remaining indicates the addition of weight to the bedding 
material by the dam, in most cases by the addition of water.  
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We used the same set of nursing females and litters as the weight transfer experiment (Figure 
2.6, a. and 2.6, b.), and also repeated two litters for each female at three different time points, 5, 
10, 15 dpp.   
 
Figure 2.12. Raw nest-building data from dams with 15 dpp pups. The table displays the percent 
of the original bedding material that was still left at each time point from all four genotypes 
tested (MMTV-Cre/WT, MMTV-Cre/FlpKO, Nkx2.1-Cre/WT, Nkx2.1-Cre/FlpKO). Dams with 
WT genotypes are in black, while dams harboring the FlpKO allele are in Red.  Red dashed lines 
indicate  borders  used  to  separate  the  “Good”,  “Mediocre”  and “Bad”  nesting  behaviors  in  Figure 
2.9, b. >100% bedding material remaining indicates the addition of weight to the bedding 
material by the dam, in most cases by the addition of water.  
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Overall, the outcomes were consistent and reproducible among individual sets of experiments.  
Regardless of genotype, we observed that the nest-building behavior of the animals was the most 
obvious during the early stage of nursing, at 5 dpp.  Once the pups have fur (around 10 dpp), this 
behavior of the nursing female slowly diminished (Figure 2.9, b., Figure 2.11 and Figure 2.12).  
Nest building behavior was also the most obvious in the first litter for each female.  In 
summation, the results from this series of experiments indicated that females with the mutation 
of Peg3 in both the MMTV-driven and Nkx2.1-driven Peg3 mutation have a problem in the nest-
building behavior compared to their littermates.  This nest-building behavior appears to be a 
subtle behavior of the mouse that is very closely associated with the dosage and functional sites 
of Peg3, since a deletion of Peg3 in both MMTV and Nkx2.1-driven tissue affects the trait.       
 
2.4 Discussion 
In the current study, two new mouse lines targeting the Peg3 locus, Peg3FlpKO and Peg3DelKO, 
have been derived and subsequently characterized at the molecular and organismal levels.  The 
Peg3DelKO line, lacking Exon 6, displayed a set of phenotypes that are consistent with those 
observed from previous mutant alleles targeting Peg3.  The Peg3FlpKO line, containing a floxed 
allele, was also utilized to further characterize the two well-known phenotypes of Peg3, a defect 
in the milk letdown process and in the nest-building  behavior.    According  to  the  results,  Peg3’s  
role in the mammary gland appears to be critical for the milk letdown process.  In contrast, 
Peg3’s  role  in  both  the  MMTV- and Nkx2.1-expressing tissues is important for the nest-building 
behavior.  Overall, the current study introduced two additional mutant lines targeting Peg3, and 
also further characterized the mutant phenotypes of Peg3 in terms of its tissue specific 
contribution.  
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The new mutant line Peg3DelKO displayed a similar set of phenotypes that have been seen from 
the other mutant alleles of Peg3 (Figure 2.3).  It is worthwhile to compare this new allele with 
the other existing mutant alleles of Peg3.  This new mutant allele lacks only a small portion of 
the genomic region, a 600-bp region containing Exon 6 (Figure 2.2, a.), whereas the other alleles 
have an insertion of large expression cassettes in either Exon 5 or Intron 5 (7,10).  The mode of 
operation in these loss-of-function mutant alleles is also quite different.  In the case of the 
Peg3DelKO allele, the transcription of Peg3 is not affected at all, but the translation of the mutant 
transcript is affected, thus causing a complete abrogation of the PEG3 protein (Figure 2.2, d.).  
By contrast, the two existing models truncate the transcription of Peg3 through the Poly-A 
signals that have been included as part of the expression cassettes.  Thus, the transcription of 
Peg3 is affected in both mutant models.  This could have potential side effects since the 
transcription and/or transcript of an imprinted gene is known to influence the function of the 
adjacent  genes.    In  that  regard,  it  is  important  to  note  that  the  3’-UTR of Peg3 contains another 
imprinted gene, APeg3 (Antisense Peg3) (16,17).  The transcriptional truncation of Peg3 (sense 
gene) might have unknown consequences on the transcription and thus function of APeg3 
(antisense gene).  Besides these differences, the two existing mutant models have an insertion of 
relatively large genomic fragments, spanning 5 to 7 kb in length, which might also have 
unknown effects on the locus itself and/or the adjacent imprinted genes.  Nevertheless, all three 
models seem to have a common phenotype, delayed growth rate, although the newest model 
Peg3DelKO appears to have a more dramatic effect during the postnatal stage than during early 
embryogenesis (Figure 2.3).  Given this observation, we can safely conclude that the observed 
phenotype is most likely caused by the lack of the gene product, the PEG3 protein, rather than 
the other defects potentially present in each of these mutant models.  Furthermore, it is also 
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important to note that the observed phenotype is also derived from mutant mice with the pure 
genetic background, C57BL/6, ruling out any possible complications that might originate from 
differing genetic backgrounds. 
 
The Peg3FlpKO line was utilized for a series of conditional knockout experiments to further 
dissect  Peg3’s  role  in  the  milk  letdown  process  (Figure 2.6).  According to the results, the 
mutation of Peg3 in the mammary gland seems to provide a more readily detectable defect than 
the mutation in the hypothalamus.  This is quite intriguing since it has been believed that the 
main cause for this defect may be due to the reduced number of oxytocin-producing neurons in 
the Peg3 mutant mice (7).  Although we have not thoroughly analyzed this aspect of the mutant 
mice that have been used for the current study, it is difficult to envision that the MMTV-driven 
deletion of Peg3 could have a drastic effect on the number of these specific neurons in the 
hypothalamus.  Thus, we believe that this mutant phenotype of Peg3 is most likely caused by a 
defect at a more global level than at a local level.  One possibility would be that this might be 
caused by a lost connection in the oxytocin circuitry of the mutant mice, but not simply by a 
defect at one tissue.  For the milk letdown process, the oxytocin circuitry requires the proper 
communication between the hypothalamus and the mammary gland through its molecular ligand 
and receptor.  Any defect in this circuitry could easily cause a problem in the milk letdown 
process.  It is important to note that Peg3 is highly expressed in the tissues that are known to 
respond to the ligand, oxytocin, such as the ovary, uterus and placenta (2).  Thus, it is also 
possible that Peg3 might be involved in the proper function of the receptor, oxytocin receptor.  
This possibility should be particularly interesting to pursue since Peg3 has been recently 
identified as a DNA-binding transcription factor4.  It is reasonable to predict that Peg3 could 
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modulate both the ligand and receptor for this circuitry.  Thus, it would be of great interest to 
further narrow down the actual cause of this mutant phenotype in the near future. 
 
The nest-building behavior of nursing females is shown to be affected by the mutation of Peg3 in 
both MMTV- and Nkx2.1-driven lines (Figure 2.9).  In both cases, the mutant females were 
either slow or inefficient at nest-building for their pups.  This maternal caring defect is consistent 
with a previous Peg3 knockout line that was characterized for maternal care phenotypes (7).  
However, the data collected in this study also displays the limitations of these conditional 
knockout lines.  First, inherent variability in the efficiency of Cre will result in a variable degree 
of Peg3 deletion among different individuals (even among littermates with the same genotype, 
Figure 2.5, Figure 2.10, Figure 2.11 and Figure 2.12). Second, as the conditional deletions of 
Peg3 rarely result in 100% deletion in the tissues targeted, this limits our ability to understand 
the full contribution of Peg3 in these tissues.  Despite these two limitations, these results help us 
understand the functions of Peg3 in regards to expression sites and dosage, as two general 
patterns also emerge from our data.   First, only the MMTV-driven deletion of Peg3 impacted 
lactation, while either the Nkx2.1- or the MMTV-driven deletion of Peg3 resulted in behavioral 
effects.  This suggests that the behavioral phenotype is more sensitive to dosage changes than the 
more physiological, lactation phenotype.  Second, there was no significant difference in growth 
of the Peg3 conditional knockouts, yet effects on lactation and maternal care were still observed 
(Figure 2.4, Figure 2.6 and Figure 2.9).  This suggests the growth effects may require the 
mutation of Peg3 at a more global level than the lactation and maternal care phenotypes.  
Overall, the results displayed a hierarchy of phenotypes in response to a loss of Peg3, the 
germline deletion exhibited all phenotypic effects, while both the MMTV and Nkx2.1-driven 
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deletion presented nest-building effects and only the MMTV-driven deletion demonstrated 
lactation effects.   
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CHAPTER THREE 
APEG3:  REGULATION OF PEG3 THROUGH AN EVOLUTIONARILY CONSERVED 
NCRNA* 
 
3.1 Introduction 
APeg3 is  an  antisense  gene  that  is  located  within  the  3’-untranslated region of an imprinted gene, 
Peg3 (Paternally expressed gene 3).  The expression of APeg3 is detected only in  
vasopressinergic neurons of the hypothalamus, suggesting a very specialized role in the neuronal 
cells controlling blood pressure and the volume of bodily fluid in mammals (1).  In fact, APeg3 
was initially identified as a gene that is highly up-regulated in response to osmotic challenges in 
rat brains (1).  Studies on Peg3 also demonstrate up-regulation against osmotic stress in this cell 
type, suggesting both APeg3 and Peg3 may play important roles in the functions of vasopressin-
expressing neurons (2).  Earlier studies from rat brain suggest APeg3 might code for a small-
sized Open Reading Frame (ORF), but were not substantiated by later studies as the observed 
ORF is not conserved in other mammals, such as humans and mice.  Interestingly, APeg3 is also 
maternally imprinted as seen in Peg3: only the paternal allele is expressed while the maternal 
allele is repressed (3).  Nevertheless, the functional impetus for APeg3 imprinting is currently not 
well understood. 
   
APeg3 is one of several ncRNA genes that have been identified from mammalian imprinted 
domains.  The list of the imprinted ncRNA genes includes H19, IPW, Kcnq1ot1, Nespas, Airn, 
Copg2, and Gtl2 (4).  APeg3 is very unique compared to the other imprinted ncRNA genes in the  
_____________________ 
*Reprinted with permission of Gene 
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following aspects.  First and foremost, APeg3 is the only imprinted antisense transcript expressed 
from the same (paternal) allele as its sense counterpart. Similar antisense ncRNA counterparts to 
imprinted genes, such as anti-Rtl1 and Copg2-AS, are selectively expressed from the opposite 
allele as the sense genes (5, 6).  Secondly, the size of APeg3 is relatively small, 1.5 kb in length, 
whereas the size of the other imprinted non-coding genes range up to several hundreds of kb in 
length (1, 4).  H19 is the only other imprinted ncRNA of similar length at ~1.9 kb (7).  Thirdly, 
APeg3 lies antisense to the protein-coding gene, Peg3.  Furthermore, the transcribed region 
overlaps  with  the  3’UTR  of  Peg3.  This is quite different from other imprinted ncRNA genes, 
such as Gtl2, which tend to overlap with the entire imprinted region.  Finally, the transcript of 
APeg3 is detected as an intronless mRNA with poly-A tails in vivo, suggesting that APeg3’s  
mRNA goes through normal processes as Pol II transcripts (3).  By contrast, other long ncRNA 
genes, such as Airn, Kcnqot1, and Rian reside inside the nucleus and do not go through normal 
processes as Pol II transcripts.  Despite these unique features, the biological roles of APeg3 are 
currently unknown.  However, given the antisense/sense relationship between APeg3 and Peg3, 
it is reasonable to predict the main function of APeg3 may be controlling the transcription and 
protein levels of Peg3.  To investigate this possibility, we performed a series of comparative 
genomics and cell-line based functional assays in the current study.  The results suggest APeg3 
may have evolved as a ncRNA gene controlling Peg3 mRNA and protein levels. 
 
3.2 Materials and Methods 
3.2.1 Database search and gene prediction 
The intronless human antisense transcript, PEG3-AS1 (NR_023847.2), was used as a reference 
sequence in the BLAST program offered through UCSC genome browser 
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(http://blast.ncbi.nlm.nih.gov/Blast.cgi).  Using this sequence, homologous nucleotide sequences 
were obtained from the available genome sequences of multiple mammalian species.  After our 
initial inspection of the retrieved sequences, one representative sequence from each order of 
placental mammals was used for sequence alignment with the ClustalW multiple sequence 
alignment (www.genome.jp/tools/clustalw/) as well as CLC Bio Workbench.  The 1.5-kb 
genomic  region  for  each  species’  APeg3 gene is as follows:  
  
Mus musculus for Rodentia (GRCm38/mm10 chr7: 6,706,295-6,707,624), Homo sapiens for 
Primates (GRCh37/hg19) chr19:57,323,893-57,325,161), Equus caballus for Perissodactyla 
(Broad/EquCab2 chr10: 25,780,355-25,781,617), Oryctolagus cuniculis for Lagomorpha 
(Broad/oryCun2 chrUn0113: 622,308-623,587), Loxodonta africana for Proboscidea 
(Broad/loxAfr3 scaffold_4: 18,505,516-18,506,810), Tursiops truncatus for Cetacea (Baylor 
Ttru_1.4/turTru2 JH478484: 13,610-14,893), Myotis lucifugus for Chiroptera (Broad Institute 
Myoluc2.0/myoluc2 GL430552: 92,812-94,034), Dasypus novemcinctus for Cingulata 
(Baylor/dasNov3 JH562679: 85,036-86,329) and Trichechus manatus for Sirenia (Broad 
v1.0/triMan1 JH594782: 4,734,304-4,735,606).  These sequences were further analyzed to 
identify several sequence features for the transcribed region of APeg3.  Transcription Start Site 
(TSS) and Poly-A site were identified based on switchgear analyses.  A potential TATA box was 
identified 25-bp upstream of the TSS site as an evolutionarily conserved element.  A target site 
for miR-124 was also identified based on TargetScan (http://www.targetscan.org/) data.  The 
results of these analyses are readily available on the UCSC genome browser.   
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3.2.2 Secondary structure prediction of APeg3 
The primary sequence alignment of APeg3 was used as an input for covariant and minimal fold 
energy (MFE) analysis using Vienna Suite software (8).  RNA folding was predicted using the 
following two programs: RNA AliFold (http://rna.tbi.univie.ac.at/cgi-bin/RNAalifold.cgi) to 
predict the macro-secondary structures (global folds) and RNAz 
(http://www.tbi.univie.ac.at/~wash/RNAz/) to predict the micro-secondary structures (local 
folds) of APeg3 (8, 9).  The programs used the primary sequence alignments to generate a 
consensus fold structure for APeg3.  This series of analyses used two controls.  The sequence of 
the H19 gene was included as a positive control, which has been previously shown to have 
significantly conserved secondary structures important for its function as a lncRNA (11), and a 
shuffled sequence of APeg3 was also included as a negative control.   
 
3.2.3 Construction and transfection of APeg3 overexpression vectors 
To construct the Short- and Full-length APeg3 expression vectors, the cDNA prepared from 
adult mouse brains were amplified with artificial BamHI and NotI sites using the following 
primers:   
APeg3 Full-length -  
APeg3Full_BamHI CGCGGATCCGGGAATTAAGTCTGGAGACACAAAGATCTAAGG and  
APeg3Short_NotI ATAAGAATGCGGCCGCGCACCAGTGCAGGTGGTGCGGA.  APeg3 
Short- APeg3Short_BamHI CGCGGATCCCAATCAGTCTCAAGGGGTCTGGGT and 
APeg3Short_NotI ATAAGAATGCGGCCGCGCACCAGTGCAGGTGGTGCGGA.  (-)APeg3 
Full-length - 
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(-)APeg3Short_BamHI CGCGGATCCGCACCAGTGCAGGTGGTGCGGA and (-
)APeg3Full_NotI 
ATAAGAATGCGGCCGCGGGAATTAAGTCTGGAGACACAAAGATCTAAGG 
(-)APeg3 Short-length –  
(-)APeg3Short_NotI ATAAGAATGCGGCCGCCAATCAGTCTCAAGGGGTCTGGGT  (-
)APeg3Short_BamHI CGCGGATCCGCACCAGTGCAGGTGGTGCGGA 
The amplified products were digested with BamHI and NotI and cloned into pCDNA3.1Hygro(-) 
vector (Invitrogen).  In this vector system, the expression of APeg3 was driven by the CMV 
promoter and terminated by the Poly-A signal of BGH.  The constructed vectors were transfected 
into Neuro2A cells with each well containing 0.15x10^6 cells using 4 uL lipofectamine 2000 
(Invitrogen).  Transfections were carried out in triplicate with 3 wells designated for subsequent 
RNA isolation and 3 wells for protein extraction.  The transfected cells were selected using 500 
ug/mL hygromycin B 24 hours post-transfection.  The cells were harvested for RNA isolation 
using TRIzol (Invitrogen) 48 hours post-transfection, and also for protein extraction in lysis 
buffer (0.25M Tris–HCl, pH 7.8, plus 0.1% NP-40)  supplemented  with  fresh  β-mercaptoethanol 
and the proteinase inhibitor cocktail (Calbiotech). 
 
3.2.4 cDNA synthesis and quantitative Reverse-Transcription PCR (qRT-PCR) 
Total RNA was isolated from transfected Neuro2A cells using a commercial kit (Trizol, 
Invitrogen).  The isolated RNA was first reverse-transcribed using the MLV First-Strand 
Synthesis System (Invitrogen) with random and oligo dT primers.  Subsequent cDNA was used 
as a template for qRT-PCR.  This analysis was performed with the iQ SYBR green supermix 
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(Bio-Rad) using the iCycler iQTM multicolor real-time detection system (Bio-Rad).  All qRT-
PCR reactions were carried out for 40 cycles under standard PCR conditions.  The expression 
levels of Peg3 were first normalized to those of β-Actin, then compared to those of the empty 
vector (pCDNA) controls.  The primers for Peg3 and β-Actin were as follows: Peg3-1a  (5’-
GGTTCAGTGTGGGTGCACTAGACT-3’),  Peg3-1b.1  (5’- 
GCTCACACCCAAGGGCTTGAGCGT-3’), Peg3-1b.3  (5’-
TCCCTAGTGTGCATGATCTGGT-3’), bactin-1a  (5’-GAGCACCCTGTGCTGCTCACCGA-
3’)  and  bactin-1b  (5’- CTCTTTGATGTCACGCACGATTTC-3’). 
 
3.2.5 Protein isolations and western blots 
The transfected Neuro2A cells were first rinsed with 1X PBS, and lysed with the lysis buffer 
(0.25M Tris–HCl, pH 7.8, plus 0.1% NP-40).  The subsequent crude lysates were collected and 
snap-frozen in liquid nitrogen.  Later, the lysate were then thawed at 4°C to prevent protein 
degradation.  The cellular debris was removed by centrifugation for 10 minutes at 4°C.  Protein 
concentrations were determined by the Bradford assay kit (Pierce), using diluted BSA as protein 
standards.  Sixty micrograms of each lysate were separated on 10% SDS–PAGE gels and 
transferred to PVDF membranes (Hybond-P, Amersham) using a Mini Trans-Blot wet transfer 
cell (Bio-Rad).  Membranes were blocked for 1 hour in the Tris-buffered saline containing 1% 
skim milk and 0.05% Tween100, and incubated overnight at 4°C with the custom-made anti-
PEG3 antibody (12).  These blots were incubated for an additional 1 hour with the secondary 
antibody linked to horseradish peroxidase (Sigma).  The blots were developed using the Western 
blot  detection  system  according  to  the  manufacturer’s  protocol  (Intron  Biotech).    Densitometry  
was measured using Jmol: an open-source Java viewer for chemical structures in 3D. 
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3.3 Results 
3.3.1 APeg3 as an evolutionarily conserved ncRNA in placental mammals 
To analyze the evolutionary conservation of APeg3, human PEG3-AS1 sequence (NR 023847.2) 
was used as a probe to search the UCSC genome browser, yielding genomic sequences for each 
of the 9 eutherian orders.  Multiple sequence alignments were performed using the 9 
representative sequences, and the results were visualized as a graph in the bottom panel of Figure 
3.1.  The UCSC PhyloP-derived placental mammal sequences used for the zoomed-out 
conservation includes multiple species corresponding mainly to primate lineages as these are the 
most complete sequenced genomes and does not account for gaps in sequences.  In this way, the 
conservation analysis could be biased.  However, our custom zoomed-in conservation was 
derived from only one representative species of each order within the class eutheria, offering an 
unbiased characterization of the region.  Differences in conservation level between the zoomed-
out view and the zoomed-in view are the result of hand-picking genomic regions of APeg3 to 
enhance the accuracy of the initial PhyloP conservation.  High levels of sequence conservation 
are again observed throughout the 1.5-kb region with many small-size insertions/deletions 
specific to individual species, which can be seen as sudden drop-offs in the graph.  Several 
sequence motifs, important for Pol II transcription, are also found within or around this 1.5-kb 
genomic region, including a TATA box, Transcription Start Site (TSS) and two Poly-
Adenylation sites.  However, there are no ORFs or Kozak sequences that are conserved among 
placental mammals.  These results suggest the 1.5-kb genomic region of APeg3 is a gene 
template for a poly-adenylated non-coding RNA (ncRNA).       
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Figure 3.1. Evolutionary conservation of APeg3 among placental mammals.  UCSC Genome 
Browser Mus musculus assembly 9 (mm9) displays the 100-kb genomic region surrounding 
mouse APeg3.  The transcribed and exon regions of Peg3 and Zim1 are also presented along 
with the transcribed region of APeg3.  Evolutionary conservation of this genomic interval among 
placental mammals is shown with a graphical output of the PhyloP analysis.  PhyloP 
conservation  analysis  of  Zim1  3’  UTR  is  designated  in a red box.  In a zoom-in view, two black 
boxes represent the different-length known cDNAs for APeg3.  APeg3-Full is based on the 
deposited cDNA sequences from human and rat, while APeg3-Short is based on the cDNA 
sequences from mouse.  The evolutionary conservation of APeg3 was further analyzed using the 
genomic sequences obtained from 9 representative placental mammals (Supplemental Figure 
3.1).  This analysis identified a highly conserved TATA box (TATA), transcriptional start site 
(TSS) and a poly-adenylation signal (pA1).  This analysis also confirmed the conservation of a 
potential target site for miRNA (miRNA-124).  Areas of high conservation within these regions 
are underscored in red. 
 
 
Using these sequences, pairwise sequence comparison analyses were also conducted, and the 
results indicated high levels of sequence conservation between different mammals: 76 to 84% 
nucleotide sequence identity in the 1.5-kb transcribed region of APeg3 (Table 3.1).   
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Table 3.1 Nucleotide Conservation of APeg3 
Organism E. 
caba
llus 
T. 
trunca
tus 
M. 
lucifug
us 
L. 
africa
na 
T. 
manat
us 
D. 
novemci
nctus 
M. 
muscul
us 
O. 
cunicu
lis 
H. 
Sapie
ns 
Equus 
caballus 
100 84.73 82.41 77.93 79.82 78.56 75.5 80.18 83.2 
Tursiops 
truncatus 
84.7
3 
100 79.78 75.12 76.47 75.23 71.66 77.13 80.99 
Myotis 
lucifugus 
82.4
1 
79.78 100 74.03 74.92 73.96 72.64 77.18 79.22 
Loxodonta 
africana 
77.9
3 
75.12 74.03 100 89.01 77.34 68.61 73.15 75.53 
Trichechus 
manatus 
79.8
2 
76.47 74.92 89.01 100 79.1 70.19 74.41 77.78 
Dasypus 
novemcinctus 
78.5
6 
75.23 73.96 77.34 79.1 100 69.5 74.17 76.42 
Mus musculus 75.5 71.66 72.64 68.61 70.19 69.5 100 79.18 77.33 
Oryctolagus 
cuniculis 
80.1
8 
77.13 77.18 73.15 74.41 74.17 79.18 100 83.84 
Homo Sapiens 83.2 80.99 79.22 75.53 77.78 76.42 77.33 83.84 100 
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The high levels of sequence conservation detected within the 1.5-kb region are also unusual, and 
can  be  contrasted  with  the  3’-UTR of an adjacent gene, Zim1, which shows no sequence 
conservation (Mammalian Cons Plot in Figure 3.1).  Overall, the high level of primary sequence 
conservation further supports the region has not evolved simply as an UTR for the sense gene, 
Peg3.  Instead, this region demonstrates signs of selection as a ncRNA gene during mammalian 
evolution. 
 
 
3.3.2 Global and local secondary structure of APeg3 with evolutionary conservation 
To determine potential functions of APeg3 as a structural ncRNA, secondary structure 
predictions were performed using RNAalifold and RNAz programs.  First, RNAalifold uses 
sequence alignments and determines folding free energies of relatively large RNA sequences 
(>200 bp) (13).  This program produces a consensus fold structure based on the lowest folding 
energy modeled and weights the conservation of folded structures among individual sequences.  
Both APeg3 and the corresponding reverse complement (-)APeg3 alignment were analyzed using 
RNAalifold to detect potential large-scale secondary structures in both orientations.  This series 
of analyses also used two controls: H19 as a positive control, an imprinted ncRNA previously 
seen to harbor functional characteristics of similar length to APeg3, and a shuffled APeg3 
alignment as a negative control.  According to the outcomes of the prediction (Figure 3.2), the 
sense and antisense APeg3 exhibit similar conservation levels of secondary structure with 
different overall structures.   
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Figure 3.2. Predicted secondary structures of APeg3 mRNA.  The 1.5-kb nucleotide sequences 
from 9 representative mammals were used to predict the global secondary structures of APeg3 
using the Alifold prediction program: sense (A) and antisense (B) strand of APeg3.  Conserved 
bases are color-coded based on their conservation level (legend inset).  Local secondary 
structures were also modeled using the lowest fold energy as well as covariant analysis on small 
(100 bp) windows within APeg3.  The RNAz program predicted a single conserved hairpin-loop 
structure within the sense (P=0.91) and antisense (P=0.99) APeg3 transcripts (C, D) with the 
98.93% folding accuracy.  The predicted hairpin-loop structure is located in  the  5’side  of  the  
APeg3 transcript (nucleotide positions 145-185 in mouse APeg3). 
 
Second, the RNAz program was used to detect any conserved micro-secondary structures within 
APeg3.  The program analyzes multiple sequence alignments and recognizes conserved fold 
structures in small (200 bp) sliding-windows (9).  These folds are based on the lowest MFE of 
each short sequence.  Covariant analysis was then performed on each fold and the resulting folds 
were scored by the program.  In this program, a class probability (P) is used to measure the 
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likelihood of a fold.  The program uses a cutoff of P=0.9, which can accurately predict 75% of 
known ncRNAs and classify folds with 99% specificity (8).  According to the outcomes, a single 
fold was predicted for APeg3 in the 1.5-kb interval (Figure 3.2, C).  The fold was conserved at 
the 5'-side of the transcript (nucleotide position 145-185 in NR 023846.1) (P=0.99).  
Interestingly, the antisense of APeg3 also displayed one conserved stem-loop structure, located at 
the 3’-side of the transcript (P=0.91) (Figure 3.2, D).  Overall, these secondary structure fold 
predictions indicate the presence of a conserved hairpin loop structure in both sense and 
antisense orientations of APeg3.  A series of predictions were also conducted using two controls, 
H19 and the shuffled APeg3.  This series of analyses predicted a known small fold, miR675, 
within H19 (P=1.0), and only one insignificant fold within the shuffled APeg3 (P=0.76); 
confirming the sensitivity of the RNAz program.  
 
3.3.3 APeg3 down-regulates Peg3 mRNA 
As seen in many antisense transcripts (14, 15), the potential function of APeg3 may be to 
regulate the expression of the sense gene, Peg3.  To determine whether APeg3 has the potential 
to regulate Peg3, we performed a series of in vitro experiments as described below.  We have 
constructed 4 expression vectors containing the different portions of mouse APeg3: APeg3-Full 
and -Short in both sense and antisense directions (the extent of APeg3-Short is indicated in 
Figure 3.1).  After transfections of these vectors to Neuro2A cells, we measured Peg3 mRNA 
levels using qRT-PCR (Figure 3.3).   
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Figure 3.3.  Effects of APeg3 overexpression on the transcription levels of Peg3.  A series of 
constructs transcribing APeg3 were transfected into Neuro2A cells.  APeg3 transcription was 
driven by the Cytomegalovirus (CMV) promoter, and terminated and polyadenylated by a 
Bovine Growth Hormone (BGH) terminator.  Transfected cells were selected with hygromycin 
antibiotic (500 mg/mL).  Potential effects of APeg3 overexpression were measured by 
determining the transcription levels of Peg3 using the total RNA isolated from the transfected 
cells with qRT-PCR.  The transcription levels of Peg3 was first normalized to β-Actin, then 
compared to a control (pCDNA, empty vector).  The results derived from multiple transfections 
(n=6) with each trial representing three individual wells were summarized and presented as 
graphs with standard deviations.  Asterisks represent statistically significant changes in the 
transcription levels of Peg3 between two constructs. 
 
 
 
This series of expression analyses used an empty vector as a control (pCDNA).  Overexpression 
of APeg3-Short resulted in down-regulation of Peg3 by 57.60 ± 0.4% (P=0.0034), whereas 
overexpression of (-)APeg3-Short resulted in a much smaller change in Peg3 expression (27.80 ± 
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0.16%)(P=0.0536).  On the other hand, overexpression of APeg3-Full caused a much greater 
down-regulation of Peg3 (81.32 ± 0.03%) (P=0.0008), which was ~20% lower expression than 
those from APeg3-Short.  Interestingly, however, overexpression of (-)APeg3-Full also caused 
down-regulation of Peg3 (49.30 ± 0.054%)(P=0.0271).  Given the results from the both 
directions of APeg3-Full, the observed down-regulation by APeg3-Full may be orientation-
independent.  Furthermore, it is possible that the potential region causing this down-regulation 
might  be  located  within  the  5’-side of the 1.5-kb region of APeg3 since this down-regulation is 
much more obvious in the Full-length constructs than in the Short-length constructs lacking the 
5’-side of APeg3.  To account for any minor transcriptional variants of Peg3, we also performed 
the previous qRT-PCR with primers amplifying the entire Peg3 transcript (Peg3-1a, Peg3-1b.3) 
and observed a similar trend (Figure 3.4).  Peg3 mRNA levels were decreased in transfections of 
APeg3-Short (71.43 ± 0.056%)(P=0.0118), APeg3-Full (11.13 ± 0.0635%)(P=0.0229) and (-
)APeg3-Full (24.61 ± 0.237%)(P=0.0332), while changes in Peg3 mRNA were not statistically 
significant in the  (-)APeg3-Short (54.18 ± 0.425%)(P=0.2135) transfections.  However, these 
alternative forms of Peg3 have minimal contribution as compared to the major Peg3 transcript 
(16).  Taken together, these results demonstrate that APeg3 has the potential to down-regulate the 
level of Peg3 mRNA in vitro.   
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Figure 3.4. qRT-PCR amplifying larger portion of the Peg3 transcript. Representative qRT-PCR 
of Peg3 from Neuro2A transfected with the respective overexpression constructs. Results are 
representative of multiple individual transfections (n=3) with at least 3 individual wells 
transfected in each trial. Standard deviations are derived from fluctuations in individual qRT-
PCR threshold cycle values for each transfection with at least 3 quantifications run for each well.  
Peg3 expression is normalized to β-Actin expression values, then compared to empty vector 
(pCDNA-transfected) cells.  Asterisks represent statistically significant changes in mRNA 
expression.   
 
 
3.3.4 APeg3 down-regulates the protein levels of PEG3 
To confirm whether the observed down-regulation of Peg3 transcript resulted in reduced levels 
of the PEG3 protein, we performed western blots with protein extracts prepared from the 
transfected Neuro2A cells (Figure 3.5).   
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 Figure 3.5.  Effects of APeg3 overexpression on the protein levels of PEG3.  A set of transfected 
Neuro2A were further analyzed using Western blotting to measure the protein levels of PEG3.  
The density of the detected PEG3 bands by anti-PEG3 antibodies was normalized to that of the 
β-ACTIN band, then compared with serial dilutions of pCDNA-transfected Neuro2A as 
standards.  Numbers below the bands describe the protein levels of PEG3 and β-ACTIN.  
Numbers within the red box indicate protein levels PEG3 relative to β-ACTIN.             
 
The protein extracts from the two samples transfected with the sense and antisense APeg3-Full, 
respectively, were analyzed and compared with those from the sample transfected with the empty 
vector (pCDNA).  The protein levels of PEG3 in each sample were first quantified using 
densitometric assays through Jmol application http://www.jmol.org, and later normalized with 
those  of  β-Actin.  The normalized values were finally compared with serial dilutions (100-40%) 
of the control sample transfected with pCDNA.  According to the results, the protein levels of 
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PEG3 were lowered by 85% in the transfectants with APeg3-Full, and by 74% in the transfectant 
with (-)APeg3-Full (lane 2 and 3 in Figure 3.5).  The reduced protein levels observed from these 
transfections with APeg3-Full are consistent with the down-regulation observed in Peg3 mRNA 
(Figure 3.3).  In conclusion, the results from both qRT-PCR and western blotting demonstrate 
that the overexpression of APeg3 indeed results in reduction in the mRNA and protein levels of 
Peg3.        
 
3.4 Discussion 
In the current study, the unknown functions of APeg3 have been investigated using two different 
approaches, comparative genomic and cell line-based functional analyses.  First, comparison of 
the sequences from different mammals revealed unusually high levels of conservation, but 
without any obvious ORF in the transcribed region of APeg3, suggesting APeg3 may have been 
selected as a ncRNA gene during mammalian evolution (Figure 3.1).  This has been further 
supported by the detection of a conserved RNA secondary structure within APeg3 (Figure 3.2).  
Second, the results from cell line-based analyses further demonstrated that APeg3 has the 
potential to down-regulate the transcription and protein levels of Peg3 (Figure 3.3 and 3.5).  
Thus, these results suggest APeg3 has likely evolved as a ncRNA gene controlling the function 
of the sense gene, Peg3. 
 
The high level of sequence conservation within the transcribed region of APeg3 is very unusual 
given the following reasoning (Figure 3.1):  The transcribed region of APeg3 does not harbor any 
obvious ORF and Kozak consensus motifs that are conserved among mammals, thus suggesting 
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APeg3 is a ncRNA gene.  This is further supported by the presence of many insertions/deletions 
in the transcribed region of APeg3 between different mammals.  At the same time, the sense 
direction of APeg3 is  part  of  the  3’UTR  of  Peg3.  In terms of functional selection during 
evolution,  both  ncRNA  and  3’UTRs  are  expected  to  have  much  less  constraints  than  the protein-
coding region of individual genes (17).  As a result, these non-coding regions should have much 
less sequence conservation than the coding regions of genes.  This can be easily observed in the 
3’UTR  of  many  genes,  including  Zim1, which shows no conservation at all (Figure 3.1).  
Nevertheless, the transcribed region of APeg3 has maintained high levels of sequence identity 
during mammalian evolution (Table 3.1), which is quite comparable to the conservation levels of 
protein-coding regions.  This might be related to the fact that this region harbors sequence 
elements for both genes, APeg3 and Peg3 with opposite transcriptional orientations.  Given this 
special situation, this is the most likely explanation for the unusual sequence conservation 
observed from APeg3, which needs further investigation in the near future.   
 
According to the results derived from in vitro transfection experiments, APeg3 has the potential 
to down-regulate expression of Peg3 (Figure 3.3 and 3.5).  The actual mechanism by which 
APeg3 down-regulates Peg3 is currently unknown, but the following scenario can be envisioned 
with the limited evidence presented in the current study.  The most dramatic down-regulation by 
APeg3 was observed with the full-length APeg3 constructs, yet this down-regulation appears to 
be somewhat orientation-independent.  The complementarity between Peg3 and APeg3 could 
allow for RNA:RNA interactions at the proposed hairpin-loop which could be causing 
transcriptional or translational interference of Peg3 via APeg3 regardless of APeg3 orientation.  
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However, in silico predictions do not correlate this interaction to be the most likely at the  5’  
hairpin-loop structure (18).     
 
Another possibility for the orientation-independent down-regulation of Peg3 is through small 
RNA-mediated silencing. There are currently four known mechanisms for small RNA to down-
regulate protein-coding mRNA, miRNA, snoRNA, pi-RNA and siRNA (20).  Of these four, the 
miRNA-mediated mechanism is mainly known to be associated with imprinted domains, and 
functions independent of orientation (19, 20).  Thus, the orientation-independent down-
regulation by APeg3 might be mediated through some unknown miRNA embedded within the 
APeg3 locus.  In that regard, it is relevant to point out the fact that  the  5’-side of APeg3 contains 
a potential target site for miR-124 (Figure 3.1), further supporting this possibility.  
 
If this is the case, is this potential miRNA from APeg3 mainly targeting the transcript from 
Peg3?  Given the similar expression profiles in vasopressin-expressing neurons, we believe Peg3 
is most likely the main target of APeg3.  However, we cannot rule out the possibility that other 
genes in those specific neuronal cells could be targeted by a potential miRNA from APeg3.  In 
conclusion, the observed down-regulation of Peg3 by APeg3 is very intriguing given the crucial 
roles played by Peg3 in eutherians, thus it would be of great interest to further investigate this 
observed down-regulation by APeg3 in terms of molecular mechanisms as well as potential 
targets.        
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CHAPTER FOUR 
SUMMARY AND FUTURE DIRECTIONS 
It is estimated that less than 1% of all genes found in the human genome are imprinted.  Yet, this 
small portion of the genome can have wide-ranging detrimental impacts on the growth and 
development of an organism when not properly regulated.  Furthermore, these genes are highly 
susceptible to environmental impacts, a direct result of lacking a functional copy in the genome.  
An understanding of the function and regulation of these imprinted genes in a tissue-specific 
context allows for a more finite definition of their roles in vivo.   
 
In this dissertation, I have characterized the imprinted transcription factor gene Peg3, known for 
its impacts on growth and reproduction.  Our data introduces the first genetically-engineered 
mouse line to abolish Peg3 activity with temporal and spatial specificity. Using this line, our data 
reveals Peg3 serves a distinct tissue-specific role in lactation and maternal care.  In the second 
part of this dissertation, we were also able to reveal the potential for APeg3 to regulate the 
expression of Peg3 as a non-coding RNA, by using comparative genomics and functional cell 
line studies.  Altogether, these studies reveal significant insights into the gene function and 
regulation of Peg3.  
 
Chapter two discusses the deletion of Peg3 in a mouse line, concentrating on defects in neonatal 
development and maternal care.  While deleting Peg3 in the germline resulted in dramatic 
neonatal growth deficiencies and the inability to care for pups, often resulting in death of the 
offspring, we aimed to identify the tissues responsible for these phenotypes.  In order to test 
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these findings, we used conditional knockout lines under the control of the Nkx2.1 and MMTV 
promoters and novel assays to detect subtle changes in milk letdown and maternal caring 
behaviors.  Our findings show that expression of Peg3 in the mammary gland is essential for 
proper milk letdown and narrowed the expression site responsible for nest-building to a site of 
expression common to both Nkx2.1 and MMTV.  These results provide a connection between 
the expression sites of Peg3 and the resulting phenotypes.   
 
As a DNA-binding protein, Peg3 is potentially responsible for the regulation of many 
downstream genes in these tissues.  Future experiments will focus on the impact of Peg3 on 
downstream genes by:  performing ChIP-seq to identify all downstream target genes; filtering the 
genes based on function and known expression site; confirming binding in vitro and in vivo by 
EMSA and ChIP, respectively; demonstrating transcriptional regulation in vitro; and generating 
binding site mutants in vivo to confirm a role in transcriptional regulation.    
 
To follow-up our results, we have performed preliminary experiments that suggest a possible 
downstream gene responsible for the lactation phenotype observed, Oxytocin Receptor (OxtR).  
To identify genes regulated by Peg3, we have performed RT-PCR in wild-type and knockout 
(Peg3CoKO) mice, focusing on imprinted genes as well as genes involved in neuroendocrine 
function.  Using regions of the fully-developed female brain known to have high expression of 
Peg3 (the supraoptic nucleus and the pituitary), we were able to assay the expression of many of 
these genes (Figure 4.1, a).  Of the genes tested, OxtR was the most highly affected at the 
transcriptional level in vivo.  Confirmation of this transcriptional change was acquired through 
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readily available 1dpp (1 day postpartum) neonatal samples, where the expression of OxtR was 
reduced by 50% through qRT-PCR (Figure 4.1, b). 
 
Figure 4.1 Imprinting and neuroendocrine panel from 6-month-old female brain and 1dpp 
neonate head. a) RT-PCR  from regions surrounding the 6-month-old mouse hypothalamus, 
including the pituitary and supraopticnucleus (SON).  The left panel includes a number of 
imprinted genes meant to test the hypothesis that Peg3 is an imprinting hub in these tissues.  The 
right panel displays a number of neuropeptides and receptors which displayed similar expression 
sites as Peg3. b) RT-PCR and qRT-PCR from Peg3 WT and CoKO pups, displaying a truncation 
of Peg3 transcript and lessened expression of OxtR.  B-Actin serves as the loading control and is 
used to normalize qRT-PCR. 
 
To assess whether regulation  of  OxtR  was  a  direct  consequence  of  Peg3’s  DNA-binding at 
promoter/enhancer sites, we performed assays to determine whether Peg3 could directly bind 
regulatory regions of OxtR.  We first identified regions which may be bound by Peg3 based on 
motifs previously defined in our lab (1).  Filtering these sites with upstream regions of OxtR that 
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show tissue-specific differential methylation, we were able to determine regions expected to be 
bound by Peg3 that may have regulatory significance (Figure 4.2, a).   
Figure 4.2  Predicted Peg3 binding sites upstream of OxtR. a) Regions used for EMSA and ChIP 
assays are highlighted on the UCSC genome browser in relation to mouse OxtR gene.  Areas 
deemed positive for Peg3 binding by their respective experiments are color-coded in green, while 
regions that did not display Peg3 binding in experimental conditions are highlighted in red.  
Regulatory elements, such as CpG islands and hypomethylated regions (HMRs) are noted below 
OxtR and are suggestive of tissue-specific sites of regulation. b) Electrophoretic Mobility Shift 
Assay (EMSA) using duplexes to compete for Peg3 binding.  Unlabeled competitor duplexes 
from OxtR upstream regions were used at [100X] to relieve Peg3 binding from radiolabeled 
Pgm2l1 probe.  Binding site  mutants  are  labeled  as  5’  and  3’  or  “w”,  corresponding  to  whole  
binding site mutants. c)  ChIP amplifying regions positive for Peg3 binding by EMSA.    
 
65 
 
Electrophoretic mobility shift assays (EMSAs) were then performed using a radiolabeled probe 
that corresponds to a region known to recruit Peg3, the promoter of the gene Pgm2l1 (1).  
Competition assays using the identified regulatory regions of OxtR, denoted as Binding Site # 
(BS#), were then used to identify the regions that could compete with the Pgm2l1 probe for 
binding of Peg3.  The results of this experiment suggest BS1 and BS3 have the ability to recruit 
Peg3 in vitro.  Once identified, the binding sites were replaced with a poly-T stretch to confirm 
Peg3 binding at the predicted binding site.  These binding sites were then mutated at the 5’  end  
and  3’  end of the Peg3 binding motif within the competitor duplex to find the bases most 
essential for binding of Peg3 (Figure 4.2, b).  The results indicate recruitment of Peg3 by BS1 
requires sequences at the  3’  end  of  the  motif.    BS3,  on  the  other  hand,  requires  specific  
sequences  at  the  5’  end  of  the  motif  to  guarantee Peg3 binding.  The results also demonstrate the 
duplexes used for BS4 and BS5 did not compete for Peg3 binding.      
 
To test whether Peg3 is binding these regions in vivo, we performed Chromatin Immuno-
precipitations (ChIP) on adult mouse brain chromatin extract using Peg3 antibody.  ChIP was 
performed in wild-type and littermate Peg3CoKO (knockout) brain chromatin extract in order to 
control for any false positives for Peg3 binding. Input (pre-precipitation DNA) and IgG (pre-
immune sera) controls were also used to demonstrate the fold-enrichment of the specified DNA 
over background pull-down by nonspecific antibody serum.  Regions amplified in ChIP 
experiments were based on EMSA regions, using primers that flanked these regions by ~50 bp. 
on each side (Figure 4.2, c).  Although successful amplification of BS3 could not be achieved, 
these results indicate BS1 and BS5 are enriched in DNA precipitated with Peg3 antibody.  
Furthermore, based on our preliminary (semi-quantative) findings, these regions appear to have 
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high enrichment as compared to a region of Pgm2l1 known to show enrichment for Peg3 
binding.  Consistent with the in vitro EMSA data, BS4 does not show enrichment upon 
precipitation with Peg3 antibody.  BS5, on the other hand, was shown to recruit Peg3 binding in 
vivo by ChIP, but not in vitro using EMSA.  These results are confounding, but can be explained 
when considering the regions amplified in ChIP experiments are larger than the potential binding 
sites tested in vitro.  The results for BS5 suggest the extra sequence amplified in the ChIP 
experiments may be responsible for recruitment of Peg3 and will need to be tested in future 
studies.   
 
Taken together these studies suggest  a  linkage  between  Peg3  and  OxtR  through  Peg3’s  DNA-
binding capability.  Furthermore, this connection provides a plausible downstream gene that 
could be responsible for the lactation defects observed in Peg3 knockout lines.  In future studies, 
it would be beneficial to pursue this angle further.  Finding the molecular mechanism responsible 
for the repression of OxtR in Peg3-deficient  mice  and  further  confirming  Peg3’s  regulation  of  
OxtR in vivo are the next steps necessary in characterizing the network from Peg3 to OxtR to 
lactation.    
 
Chapter three discusses the evolutionary conservation, secondary structure and regulatory 
function of APeg3 as a non-coding RNA with the potential to suppress the expression of Peg3.  
Genomic studies revealed the conservation of APeg3 as a ncRNA at the primary (sequence) and 
secondary (structural) level,  identifying  a  conserved  secondary  structure  at  the  5’  end.  Functional  
cell line studies demonstrate the ability of APeg3 to down-regulate Peg3 transcript in vitro. This 
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chapter also identifies a conserved 5’  extension of APeg3 transcript in mice and shows the region 
to mediate additional silencing in an orientation independent manner.       
 
Genomic studies show the conservation of a transcriptional start site and poly-adenylation signal 
for APeg3 in 9 orders of eutherian mammals.  Alongside the absence of a conserved ORF, these 
genomic studies illustrate the occupation of APeg3 as a conserved transcriptional element, 
suggesting its function as a ncRNA.  Using this sequence information, we were also able to infer 
structural characteristics about APeg3, focusing on the macro-scale long ncRNA as well as the 
micro-scale small ncRNA folding patterns.  The conservation of a small secondary structure at 
the  5’ end of APeg3 shows folding and sequence characteristics consistent with those found in 
previously annotated small RNAs, suggesting the region may function to regulate the sense gene 
through a small RNA intermediate.  Transfection experiments overexpressing the APeg3 
transcript in vitro confirm the potential of APeg3 to downregulate Peg3 in a neuronal cell line, 
Neuro2A.  These transfection experiments, along with the secondary structure analyses also 
provide a more in-depth explanation of how this silencing occurs.  While Peg3 silencing only 
occurs  when  the  3’  region  of  APeg3  is  overexpressed  in  the  correct  orientation,  the  extended 5’  
end confers additional silencing potential in both orientations.  The orientation-independent 
silencing is characteristic of micro-RNA (miRNA), a class of small RNAs which function to 
regulate their sense counterparts through post-transcriptional gene silencing.   
 
We hypothesize the function of APeg3 in vivo will be similar to its function in vitro (in cell 
culture assays), regulation of Peg3.  However, unlike Peg3, expression of APeg3 is limited to 
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vasopressinergic neurons in the brain,  suggesting  the  transcript’s  function  will  be  highly  cell-
type specific. Future experiments for APeg3 will concentrate on two aspects, the detection of 
small RNA intermediates from APeg3 transcript and the function of APeg3 in vivo, focusing on 
its expression and upregulation in salt-dependent, vasopressinergic cells. 
 
The first aspect will be the detection of smRNA originating from the 1.5 Kb, full length APeg3 
transcript.  Detection of smRNA is historically accomplished through northern blots and smRNA 
amplification using fluorescently labeled probes (2, 3, 4).  However, these assays are prone to 
low sensitivity and high background, respectively.  The best strategy to assay the production of 
smRNA from a large transcript, such as APeg3, is through radiolabeled in vitro transcription of 
APeg3, followed by incubation with nuclear extracts from Neuro2A cells.  If APeg3 serves as a 
pri-miRNA, then incubation with nuclear extracts should result in distinguishable smRNA 
products, which can then be sequenced through conventional cloning and Sanger sequencing.  
Known precursor RNAs, such as H19, should be used as controls to test the validity of the 
system (5).  
 
The second aspect of APeg3 centers on the function of APeg3 in vivo.  While the best way to 
examine  a  gene’s  function  in vivo is to produce animals that have deletions in the gene, antisense 
genes have specific caveats that must be taken into account.  As regions of APeg3 overlap with 
the coding region and 3’  UTR of Peg3, deletions of APeg3 will likely produce unintended 
defects in Peg3 expression.  The best option for affecting APeg3 expression without perturbing 
Peg3 is to delete the promoter of APeg3.  Although we have identified a consensus TATA motif 
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upstream of APeg3, promoter assays must be performed prior to deletion in mice.  Once 
transcriptional regulation by this promoter is confirmed, a mutation/deletion of this region can 
result in a change of the APeg3 mRNA, without a change in the transcription or translation of 
Peg3.  Another approach could use findings from the characterization of the predicted miRNA to 
yield sites that could be mutated based on their secondary structure, resulting in an optimal 
situation for characterizing the potential of this secondary structure in the silencing of Peg3 in 
vivo.  Once these APeg3 mutant mouse lines are created, they can then be crossed with our 
Peg3CoKO reporter line  to  assay  β–Galactosidase activity in fixed brain tissues under conditions of 
salt stress.  I believe this ncRNA serves a role in regulating expression of Peg3 in 
vasopressinergic cells when expression of Peg3 is too high.  This could be due, in large part, to 
Peg3’s role in autophagy or apoptosis and could function to modulate the actions of Peg3.  In 
these cells, following salt exposure, Peg3 could be acting to replenish the peptide 
neurotransmitter, vasopressin, through cycling of cellular proteins.  Central nervous cells are 
irreplaceable, thus APeg3 could be acting as a safeguard, modulating Peg3 expression, to 
maintain viability of the cell.  A proposed model for this relationship is shown (Figure 4.3).  This 
model takes into account the upregulation of Peg3 in response to high salt concentrations in vivo, 
as well as the recently described role of Peg3 as a master regulator of autophagy.   
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Figure 4.3  Evidence and proposed role for Peg3 in vasopressin replenishment. A vasopressin 
neuron is shown, with the nucleus (N) represented in yellow and the cytoplasm (Cyto) 
represented in blue, genes within the nucleus are represented as colored boxes and vasopressin, 
within vesicles and being released into the synapse, is represented by black circles.  mRNA 
transcripts from Peg3 and APeg3 are represented by wavy red lines with poly-adenylation 
represented as An.  Extracellular and intracellular changes, in relation to Peg3, as a response to 
high extracellular salt (hyperosmotic stress) are represented as steps 1, 2, 3 and 4. Evidence for 
the outcomes observed are separated by two manuscripts, a=Glasgow et al. 2005 and b=Buraschi 
et al. 2013. 1a) Increase in extracellular sodium 2a) Increase in Peg3 expression and increase in 
APeg3 expression. 3a) Possible post-transcriptional gene silencing by APeg3.  4a) Vasopressin 
release into synaptic cleft. 1b)Increase in Peg3 expression. 2b) Increase in Maplc3 expression. 
3b) Incorporation of PEG3, MAPLC3 and BECN1 into autophagosome.  4b) protein degradation 
for use in vasopressin synthesis. 
       
This dissertation chronicles the function and ncRNA-mediated regulation of an imprinted 
transcription factor, Peg3.  Firstly, the findings illustrate the specific tissues in which Peg3 is 
necessary for proper physiological and behavioral functions, then links these functions to a 
possible downstream gene, OxtR.  Secondly, the findings show the potential for regulation of 
Peg3 by APeg3 in a very specific cell type in the hypothalamus, suggesting a mechanism of 
smRNA gene silencing may be partly responsible.  Our study discusses the critical expression 
sites and functions of Peg3 in reproduction on the genetic, physiological and behavioral level. 
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